August 2019: Additions and Deletions to the Drug Product List

Home , Doxorubicin

Prescription and Over-the-Counter Drug Product List 39TH EDITION Cumulative Supplement Number 08 : August 2019 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE TABLET;ORAL APADAZ >D> + KVK TECH INC 325MG;EQ 8.16MG BASE N 208653 003 Jan 04, 2019 Aug CHRS >A> +! 325MG;EQ 8.16MG BASE N 208653 003 Jan 04, 2019 Aug CHRS

ACETAMINOPHEN; CODEINE PHOSPHATE TABLET;ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE >A> AA ELITE LABS INC 300MG;15MG A 212418 001 Sep 10, 2019 Aug NEWA >A> AA 300MG;30MG A 212418 002 Sep 10, 2019 Aug NEWA >A> AA 300MG;60MG A 212418 003 Sep 10, 2019 Aug NEWA

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE TABLET;ORAL OXYCODONE AND ACETAMINOPHEN >D> AA CHEMO RESEARCH SL 325MG;5MG A 207574 001 Dec 13, 2016 Aug CAHN >A> AA HALO PHARM CANADA 325MG;5MG A 207834 001 Aug 15, 2019 Aug NEWA >A> AA 325MG;7.5MG A 207834 002 Aug 15, 2019 Aug NEWA >A> AA 325MG;10MG A 207834 003 Aug 15, 2019 Aug NEWA >A> AA XIROMED 325MG;5MG A 207574 001 Dec 13, 2016 Aug CAHN

ACYCLOVIR CAPSULE;ORAL ACYCLOVIR >A> AB CADILA 200MG A 204313 001 Mar 25, 2016 Aug CAHN >D> AB ZYDUS PHARMS 200MG A 204313 001 Mar 25, 2016 Aug CAHN >D> OINTMENT;OPHTHALMIC >D> AVACLYR >D> +! FERA PHARMS LLC 3% N 202408 001 Mar 29, 2019 Aug DISC >A> + @ 3% N 202408 001 Mar 29, 2019 Aug DISC OINTMENT;TOPICAL ACYCLOVIR >A> AB APOTEX INC 5% A 210774 001 Sep 06, 2019 Aug NEWA >D> AB PERRIGO UK FINCO 5% A 205659 001 Feb 20, 2019 Aug DISC >A> @ 5% A 205659 001 Feb 20, 2019 Aug DISC

ALBENDAZOLE TABLET;ORAL ALBENDAZOLE >A> AB STRIDES PHARMA 200MG A 210011 001 Dec 07, 2018 Aug CAHN >D> AB STRIDES VIVIMED 200MG A 210011 001 Dec 07, 2018 Aug CAHN

ALBUTEROL SULFATE SYRUP;ORAL ALBUTEROL SULFATE >A> AA QUAGEN EQ 2MG BASE/5ML A 212197 001 Sep 06, 2019 Aug NEWA

AMINOCAPROIC ACID SYRUP;ORAL AMICAR >D> +! CLOVER PHARMS 1.25GM/5ML N 015230 002 Oct 26, 1970 Aug CTEC >A> AA +! 1.25GM/5ML N 015230 002 Oct 26, 1970 Aug CTEC AMINOCAPROIC ACID >A> AA AMNEAL PHARMS LLC 1.25GM/5ML A 212780 001 Aug 23, 2019 Aug NEWA

ARSENIC TRIOXIDE INJECTABLE;INJECTION ARSENIC TRIOXIDE >A> AP ZYDUS PHARMS 2MG/ML A 206228 002 Aug 30, 2019 Aug NFTG TRISENOX >D> +! CEPHALON 2MG/ML N 021248 002 Oct 13, 2017 Aug CFTG >A> AP +! 2MG/ML N 021248 002 Oct 13, 2017 Aug CFTG

Page 1 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ASPIRIN; BUTALBITAL; CAFFEINE TABLET;ORAL BUTALBITAL, ASPIRIN AND CAFFEINE >A> AA BRECKENRIDGE 325MG;50MG;40MG A 204195 001 Sep 22, 2016 Aug CAHN >D> AA PII 325MG;50MG;40MG A 204195 001 Sep 22, 2016 Aug CAHN

AZELAIC ACID GEL;TOPICAL AZELAIC ACID >A> AB TARO 15% A 210549 001 Aug 23, 2019 Aug NEWA

AZELASTINE HYDROCHLORIDE SPRAY, METERED;NASAL AZELASTINE HYDROCHLORIDE >A> AB HI TECH EQ 0.1876MG BASE/SPRAY A 210032 001 Aug 23, 2019 Aug NEWA

BACLOFEN INJECTABLE;INTRATHECAL BACLOFEN >A> AP MAIA PHARMS INC 0.5MG/ML A 210048 001 Sep 11, 2019 Aug NEWA >A> AP 2MG/ML A 210048 002 Sep 11, 2019 Aug NEWA GABLOFEN >D> AP PIRAMAL CRITICAL 0.05MG/ML N 022462 001 Nov 19, 2010 Aug CAHN >A> AP 0.05MG/ML N 022462 001 Nov 19, 2010 Aug CAHN >D> AP 0.5MG/ML N 022462 002 Nov 19, 2010 Aug CAHN >A> AP 0.5MG/ML N 022462 002 Nov 19, 2010 Aug CAHN >D> AP +! 1MG/ML N 022462 004 Jun 22, 2012 Aug CAHN >A> AP +! 1MG/ML N 022462 004 Jun 22, 2012 Aug CAHN >D> AP 2MG/ML N 022462 003 Nov 19, 2010 Aug CAHN >A> AP 2MG/ML N 022462 003 Nov 19, 2010 Aug CAHN

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE GEL;TOPICAL ACANYA >A> AB +! BAUSCH 2.5%;EQ 1.2% BASE N 050819 001 Oct 23, 2008 Aug CAHN >D> AB +! DOW PHARM 2.5%;EQ 1.2% BASE N 050819 001 Oct 23, 2008 Aug CAHN BENZACLIN >A> AB +! BAUSCH 5%;EQ 1% BASE N 050756 001 Dec 21, 2000 Aug CAHN >A> @ 5%;EQ 1% BASE N 050756 002 Apr 20, 2007 Aug CAHN >D> AB +! VALEANT BERMUDA 5%;EQ 1% BASE N 050756 001 Dec 21, 2000 Aug CAHN >D> @ 5%;EQ 1% BASE N 050756 002 Apr 20, 2007 Aug CAHN CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE >A> AB PERRIGO ISRAEL 2.5%;EQ 1.2% BASE A 205397 001 Sep 09, 2019 Aug NEWA >A> AB TARO 2.5%;EQ 1.2% BASE A 206575 001 Aug 19, 2019 Aug NEWA >A> AB TOLMAR 2.5%;EQ 1.2% BASE A 207194 001 Aug 19, 2019 Aug NEWA ONEXTON >A> +! BAUSCH 3.75%;EQ 1.2% BASE N 050819 002 Nov 24, 2014 Aug CAHN >D> +! DOW PHARM 3.75%;EQ 1.2% BASE N 050819 002 Nov 24, 2014 Aug CAHN

BENZOYL PEROXIDE; ERYTHROMYCIN GEL;TOPICAL >D> AKTIPAK >D> +! BIOFRONTERA 5%;3% N 050769 001 Nov 27, 2000 Aug DISC >A> + @ 5%;3% N 050769 001 Nov 27, 2000 Aug DISC

BRETYLIUM TOSYLATE INJECTABLE;INJECTION BRETYLIUM TOSYLATE >D> ! BAS ANDA 50MG/ML A 204386 001 Dec 21, 2018 Aug CAHN >A> ! BRECKENRIDGE 50MG/ML A 204386 001 Dec 21, 2018 Aug CAHN

BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL BUPROPION HYDROCHLORIDE >A> AB3 ZHEJIANG JUTAI PHARM 300MG A 211200 001 Sep 05, 2019 Aug NEWA

Page 2 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

BUSPIRONE HYDROCHLORIDE TABLET;ORAL BUSPIRONE HYDROCHLORIDE >D> @ APOTEX 5MG A 075521 001 Apr 05, 2002 Aug CAHN >D> @ 10MG A 075521 002 Apr 05, 2002 Aug CAHN >D> @ 15MG A 075521 003 Apr 05, 2002 Aug CAHN >A> @ RUBICON 5MG A 075521 001 Apr 05, 2002 Aug CAHN >A> @ 10MG A 075521 002 Apr 05, 2002 Aug CAHN >A> @ 15MG A 075521 003 Apr 05, 2002 Aug CAHN

CABERGOLINE TABLET;ORAL CABERGOLINE >D> AB ACTAVIS LABS FL INC 0.5MG A 078035 001 Apr 21, 2008 Aug DISC >A> @ 0.5MG A 078035 001 Apr 21, 2008 Aug DISC

CAFFEINE CITRATE SOLUTION;INTRAVENOUS CAFCIT >A> AP +! HIKMA EQ 30MG BASE/3ML (EQ 10MG N 020793 001 Sep 21, 1999 Aug CAHN BASE/ML) >D> AP +! WEST-WARD PHARMS INT EQ 30MG BASE/3ML (EQ 10MG N 020793 001 Sep 21, 1999 Aug CAHN BASE/ML) SOLUTION;ORAL CAFCIT >A> AA +! HIKMA EQ 30MG BASE/3ML (EQ 10MG N 020793 002 Apr 12, 2000 Aug CAHN BASE/ML) >D> AA +! WEST-WARD PHARMS INT EQ 30MG BASE/3ML (EQ 10MG N 020793 002 Apr 12, 2000 Aug CAHN BASE/ML)

CALCITONIN SALMON INJECTABLE;INJECTION MIACALCIN >D> @ MYLAN IRELAND LTD 100 IU/ML N 017808 001 Jul 03, 1986 Aug CRLD >A> + @ 100 IU/ML N 017808 001 Jul 03, 1986 Aug CRLD

CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE SOLUTION;INTRAPERITONEAL DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER >D> + BAXTER HLTHCARE 18.3MG/100ML;2.5GM/100ML;5.08MG N 020183 002 Dec 04, 1992 Aug CTEC /100ML;538MG/100ML;448MG/100ML

>A> AT + 18.3MG/100ML;2.5GM/100ML;5.08MG N 020183 002 Dec 04, 1992 Aug CTEC /100ML;538MG/100ML;448MG/100ML

DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER >D> + BAXTER HLTHCARE 18.3MG/100ML;4.25GM/100ML;5.08M N 020183 004 Dec 04, 1992 Aug CTEC G/100ML;538MG/100ML;448MG/100ML

>A> AT + 18.3MG/100ML;4.25GM/100ML;5.08M N 020183 004 Dec 04, 1992 Aug CTEC G/100ML;538MG/100ML;448MG/100ML

>A> DIANEAL LOW CALCIUM W/DEXTROSE 1.5% IN PLASTIC CONTAINER >A> AT + BAXTER HLTHCARE 18.3MG/100ML;1.5GM/100ML;5.08MG N 017512 012 Jan 10, 1989 Aug NEWA /100ML;538MG/100ML;448MG/100ML

>A> DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER >A> AT + BAXTER HLTHCARE 18.3MG/100ML;2.5GM/100ML;5.08MG N 017512 013 Jul 11, 1990 Aug NEWA /100ML;538MG/100ML;448MG/100ML

>A> DIANEAL LOW CALCIUM W/DEXTROSE 3.5% IN PLASTIC CONTAINER >A> AT + BAXTER HLTHCARE 18.3MG/100ML;3.5GM/100ML;5.08MG N 017512 014 Jul 11, 1990 Aug NEWA /100ML;538MG/100ML;448MG/100ML

>A> DIANEAL LOW CALCIUM W/DEXTROSE 4.25% IN PLASTIC CONTAINER >A> AT + BAXTER HLTHCARE 18.3MG/100ML;4.25GM/100ML;5.08M N 017512 015 Jul 11, 1990 Aug NEWA G/100ML;538MG/100ML;448MG/100ML

DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER >D> AT + BAXTER HLTHCARE 18.3MG/100ML;1.5GM/100ML;5.08MG N 017512 004 Oct 05, 1981 Aug CPOT /100ML;538MG/100ML;448MG/100ML

>A> AT + 25.7MG/100ML;1.5GM/100ML;5.08MG N 017512 004 Oct 05, 1981 Aug CPOT /100ML;538MG/100ML;448MG/100ML

Page 3 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CARBIDOPA; ENTACAPONE; LEVODOPA TABLET;ORAL CARBIDOPA, LEVODOPA AND ENTACAPONE >D> AB WOCKHARDT LTD 12.5MG;200MG;50MG A 090786 001 Nov 20, 2012 Aug DISC >A> @ 12.5MG;200MG;50MG A 090786 001 Nov 20, 2012 Aug DISC >D> AB 18.75MG;200MG;75MG A 090833 001 Nov 20, 2012 Aug DISC >A> @ 18.75MG;200MG;75MG A 090833 001 Nov 20, 2012 Aug DISC >D> AB 25MG;200MG;100MG A 090833 002 Nov 20, 2012 Aug DISC >A> @ 25MG;200MG;100MG A 090833 002 Nov 20, 2012 Aug DISC >D> AB 31.25MG;200MG;125MG A 090833 003 Nov 20, 2012 Aug DISC >A> @ 31.25MG;200MG;125MG A 090833 003 Nov 20, 2012 Aug DISC >D> AB 37.5MG;200MG;150MG A 090833 004 Nov 20, 2012 Aug DISC >A> @ 37.5MG;200MG;150MG A 090833 004 Nov 20, 2012 Aug DISC >D> AB 50MG;200MG;200MG A 090833 005 Nov 20, 2012 Aug DISC >A> @ 50MG;200MG;200MG A 090833 005 Nov 20, 2012 Aug DISC STALEVO 125 >D> AB + ORION PHARMA 31.25MG;200MG;125MG N 021485 006 Aug 29, 2008 Aug CTEC >A> + 31.25MG;200MG;125MG N 021485 006 Aug 29, 2008 Aug CTEC STALEVO 200 >D> AB +! ORION PHARMA 50MG;200MG;200MG N 021485 004 Aug 02, 2007 Aug CTEC >A> +! 50MG;200MG;200MG N 021485 004 Aug 02, 2007 Aug CTEC STALEVO 50 >D> AB +! ORION PHARMA 12.5MG;200MG;50MG N 021485 001 Jun 11, 2003 Aug CTEC >A> +! 12.5MG;200MG;50MG N 021485 001 Jun 11, 2003 Aug CTEC STALEVO 75 >D> AB + ORION PHARMA 18.75MG;200MG;75MG N 021485 005 Aug 29, 2008 Aug CTEC >A> + 18.75MG;200MG;75MG N 021485 005 Aug 29, 2008 Aug CTEC

CARFILZOMIB POWDER;INTRAVENOUS >A> CARFILZOMIB >A> AP DR REDDYS 60MG/VIAL A 209422 001 Sep 09, 2019 Aug NFTG KYPROLIS >D> +! ONYX THERAP 60MG/VIAL N 202714 001 Jul 20, 2012 Aug CFTG >A> AP +! 60MG/VIAL N 202714 001 Jul 20, 2012 Aug CFTG

CARISOPRODOL TABLET;ORAL CARISOPRODOL >D> @ ALLIED 350MG A 040245 001 Sep 08, 1997 Aug CMFD >A> AA 350MG A 040245 001 Sep 08, 1997 Aug CMFD

CARVEDILOL TABLET;ORAL CARVEDILOL >D> AB APOTEX INC 3.125MG A 078165 001 Sep 05, 2007 Aug CAHN >D> AB 6.25MG A 078165 002 Sep 05, 2007 Aug CAHN >D> AB 12.5MG A 078165 003 Sep 05, 2007 Aug CAHN >D> AB 25MG A 078165 004 Sep 05, 2007 Aug CAHN >A> AB RUBICON 3.125MG A 078165 001 Sep 05, 2007 Aug CAHN >A> AB 6.25MG A 078165 002 Sep 05, 2007 Aug CAHN >A> AB 12.5MG A 078165 003 Sep 05, 2007 Aug CAHN >A> AB 25MG A 078165 004 Sep 05, 2007 Aug CAHN

CEFAZOLIN SODIUM INJECTABLE;INJECTION ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER >D> @ BAXTER HLTHCARE EQ 10MG BASE/ML N 050566 003 Jun 08, 1983 Aug CRLD >A> + @ EQ 10MG BASE/ML N 050566 003 Jun 08, 1983 Aug CRLD >D> @ EQ 20MG BASE/ML N 050566 004 Jun 08, 1983 Aug CRLD >A> + @ EQ 20MG BASE/ML N 050566 004 Jun 08, 1983 Aug CRLD ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER >D> @ BAXTER HLTHCARE EQ 10MG BASE/ML N 050566 001 Jun 08, 1983 Aug CRLD >A> + @ EQ 10MG BASE/ML N 050566 001 Jun 08, 1983 Aug CRLD >D> @ EQ 20MG BASE/ML N 050566 002 Jun 08, 1983 Aug CRLD >A> + @ EQ 20MG BASE/ML N 050566 002 Jun 08, 1983 Aug CRLD

Page 4 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CETIRIZINE HYDROCHLORIDE SYRUP;ORAL CETIRIZINE HYDROCHLORIDE >A> AA MLV 5MG/5ML A 090191 001 Nov 12, 2009 Aug CAHN >D> AA SAPTALIS PHARMS 5MG/5ML A 090191 001 Nov 12, 2009 Aug CAHN

CHLORAMPHENICOL; DESOXYRIBONUCLEASE; FIBRINOLYSIN OINTMENT;TOPICAL ELASE-CHLOROMYCETIN >D> @ PARKE DAVIS 10MG/GM;666 UNITS/GM;1 UNITS/GM N 050294 001 Apr 01, 1964 Aug CRLD >A> + @ 10MG/GM;666 UNITS/GM;1 UNITS/GM N 050294 001 Apr 01, 1964 Aug CRLD

CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE SOLUTION;ORAL >D> HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE >D> AA ACELLA 4MG/5ML;5MG/5ML A 206891 001 Jun 09, 2017 Aug DISC >A> @ 4MG/5ML;5MG/5ML A 206891 001 Jun 09, 2017 Aug DISC >D> VITUZ >D> AA +! PERSION 4MG/5ML;5MG/5ML N 204307 001 Feb 20, 2013 Aug DISC >A> + @ 4MG/5ML;5MG/5ML N 204307 001 Feb 20, 2013 Aug DISC

CICLOPIROX SOLUTION;TOPICAL CICLOPIROX >A> AT ANDA REPOSITORY 8% A 077687 001 Sep 18, 2007 Aug CAHN >D> AT TOLMAR 8% A 077687 001 Sep 18, 2007 Aug CAHN

CILOSTAZOL TABLET;ORAL CILOSTAZOL >D> AB FRONTIDA BIOPHARM 50MG A 077208 002 Mar 29, 2006 Aug CAHN >D> AB 100MG A 077208 001 Mar 29, 2006 Aug CAHN >A> AB SLATE 50MG A 077208 002 Mar 29, 2006 Aug CAHN >A> AB 100MG A 077208 001 Mar 29, 2006 Aug CAHN

CLARITHROMYCIN TABLET;ORAL CLARITHROMYCIN >D> AB APOTEX CORP 250MG A 065384 001 Aug 20, 2007 Aug CAHN >D> AB 500MG A 065384 002 Aug 20, 2007 Aug CAHN >A> AB CHARTWELL 250MG A 065384 001 Aug 20, 2007 Aug CAHN >A> AB 500MG A 065384 002 Aug 20, 2007 Aug CAHN

CLOBAZAM TABLET;ORAL CLOBAZAM >A> AB ALKEM LABS LTD 10MG A 212714 001 Sep 06, 2019 Aug NEWA >A> AB 20MG A 212714 002 Sep 06, 2019 Aug NEWA

CLOBETASOL PROPIONATE AEROSOL, FOAM;TOPICAL CLOBETASOL PROPIONATE >A> AB2 GLENMARK PHARMS LTD 0.05% A 211450 001 Sep 09, 2019 Aug NEWA CREAM;TOPICAL CLOBETASOL PROPIONATE >D> AB1 CHEMO RESEARCH SL 0.05% A 210034 001 Jun 15, 2018 Aug CAHN >A> AB1 XIROMED 0.05% A 210034 001 Jun 15, 2018 Aug CAHN OINTMENT;TOPICAL CLOBETASOL PROPIONATE >D> AB CHEMO RESEARCH SL 0.05% A 209701 001 Apr 17, 2018 Aug CAHN >A> AB XIROMED 0.05% A 209701 001 Apr 17, 2018 Aug CAHN SPRAY;TOPICAL CLOBETASOL PROPIONATE >D> AT GLENMARK PHARMS 0.05% A 209004 001 Mar 26, 2018 Aug CAHN >A> AT 0.05% A 209004 001 Mar 26, 2018 Aug CAHN

Page 5 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CLONAZEPAM TABLET;ORAL CLONAZEPAM >D> @ APOTEX INC 0.5MG A 075468 001 Oct 06, 2000 Aug CAHN >D> @ 1MG A 075468 002 Oct 06, 2000 Aug CAHN >D> @ 2MG A 075468 003 Oct 06, 2000 Aug CAHN >A> @ RUBICON 0.5MG A 075468 001 Oct 06, 2000 Aug CAHN >A> @ 1MG A 075468 002 Oct 06, 2000 Aug CAHN >A> @ 2MG A 075468 003 Oct 06, 2000 Aug CAHN

CLOPIDOGREL BISULFATE TABLET;ORAL CLOPIDOGREL BISULFATE >A> AB CELLTRION EQ 75MG BASE A 202266 001 Aug 14, 2012 Aug CAHN >A> AB EQ 300MG BASE A 202266 002 Nov 20, 2012 Aug CAHN >D> AB WOCKHARDT LTD EQ 75MG BASE A 202266 001 Aug 14, 2012 Aug CAHN >D> AB EQ 300MG BASE A 202266 002 Nov 20, 2012 Aug CAHN

COLCHICINE TABLET;ORAL COLCHICINE >A> AB DR REDDYS 0.6MG A 209876 001 Sep 06, 2019 Aug NEWA

CROTAMITON >D> CREAM;TOPICAL >D> EURAX >D> +! SUN PHARM INDS INC 10% N 006927 001 Jul 06, 1949 Aug DISC >A> + @ 10% N 006927 001 Jul 06, 1949 Aug DISC

CYCLOBENZAPRINE HYDROCHLORIDE TABLET;ORAL CYCLOBENZAPRINE HYDROCHLORIDE >A> AB ANDA REPOSITORY 5MG A 073541 002 Apr 06, 2006 Aug CAHN >A> AB 10MG A 073541 001 May 23, 1995 Aug CAHN >D> AB FRONTIDA BIOPHARM 5MG A 073541 002 Apr 06, 2006 Aug CAHN >D> AB 10MG A 073541 001 May 23, 1995 Aug CAHN

CYCLOSERINE CAPSULE;ORAL SEROMYCIN >A> ! PURDUE 250MG A 060593 001 Jun 29, 1964 Aug CAHN >D> ! PURDUE GMP 250MG A 060593 001 Jun 29, 1964 Aug CAHN

DAPTOMYCIN POWDER;INTRAVENOUS DAPTOMYCIN >A> AP JIANGSU HENGRUI MED 500MG/VIAL A 212022 001 Aug 22, 2019 Aug NEWA

DECITABINE INJECTABLE;INTRAVENOUS DECITABINE >A> AP MSN LABS PVT LTD 50MG/VIAL A 212265 001 Aug 28, 2019 Aug NEWA

DESOGESTREL; ETHINYL ESTRADIOL TABLET;ORAL-28 ISIBLOOM >D> AB LABS LEON FARMA 0.15MG;0.03MG A 202789 001 Aug 12, 2015 Aug CAHN >A> AB XIROMED 0.15MG;0.03MG A 202789 001 Aug 12, 2015 Aug CAHN VOLNEA >D> AB LABS LEON FARMA 0.15MG,N/A;0.02MG,0.01MG A 202689 001 Sep 09, 2016 Aug CAHN >A> AB XIROMED 0.15MG,N/A;0.02MG,0.01MG A 202689 001 Sep 09, 2016 Aug CAHN

DEXTROAMPHETAMINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL DEXTROAMPHETAMINE SULFATE >A> AB ANDA REPOSITORY 5MG A 205077 001 Jun 21, 2019 Aug CAHN >A> AB 10MG A 205077 002 Jun 21, 2019 Aug CAHN >A> AB 15MG A 205077 003 Jun 21, 2019 Aug CAHN >D> AB MYLAN 5MG A 206735 001 Jan 27, 2016 Aug DISC >A> @ 5MG A 206735 001 Jan 27, 2016 Aug DISC >D> AB 10MG A 206735 002 Jan 27, 2016 Aug DISC

Page 6 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DEXTROAMPHETAMINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL DEXTROAMPHETAMINE SULFATE >A> @ 10MG A 206735 002 Jan 27, 2016 Aug DISC >D> AB 15MG A 206735 003 Jan 27, 2016 Aug DISC >A> @ 15MG A 206735 003 Jan 27, 2016 Aug DISC >D> AB PII 5MG A 205077 001 Jun 21, 2019 Aug CAHN >D> AB 10MG A 205077 002 Jun 21, 2019 Aug CAHN >D> AB 15MG A 205077 003 Jun 21, 2019 Aug CAHN

DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL DILTIAZEM HYDROCHLORIDE >D> AB2 APOTEX 120MG A 074943 003 Dec 19, 2000 Aug CTEC >A> 120MG A 074943 003 Dec 19, 2000 Aug CTEC >D> AB2 MYLAN 120MG A 075124 002 Mar 18, 1998 Aug DISC >A> @ 120MG A 075124 002 Mar 18, 1998 Aug DISC

DIVALPROEX SODIUM TABLET, DELAYED RELEASE;ORAL DIVALPROEX SODIUM >A> AB CELLTRION EQ 125MG VALPROIC ACID A 077296 001 Jul 31, 2008 Aug CAHN >A> AB EQ 250MG VALPROIC ACID A 077296 002 Jul 31, 2008 Aug CAHN >A> AB EQ 500MG VALPROIC ACID A 077296 003 Jul 31, 2008 Aug CAHN >D> AB WOCKHARDT EQ 125MG VALPROIC ACID A 077296 001 Jul 31, 2008 Aug CAHN >D> AB EQ 250MG VALPROIC ACID A 077296 002 Jul 31, 2008 Aug CAHN >D> AB EQ 500MG VALPROIC ACID A 077296 003 Jul 31, 2008 Aug CAHN

DORZOLAMIDE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC DORZOLAMIDE HYDROCHLORIDE >D> @ APOTEX INC EQ 2% BASE A 078395 001 Oct 28, 2008 Aug CAHN >A> @ RUBICON EQ 2% BASE A 078395 001 Oct 28, 2008 Aug CAHN

DOXEPIN HYDROCHLORIDE CAPSULE;ORAL DOXEPIN HYDROCHLORIDE >A> AB PAR PHARM EQ 10MG BASE A 071422 002 Nov 09, 1987 Aug CMS1 >A> AB EQ 25MG BASE A 071422 003 Nov 09, 1987 Aug CMS1 >A> AB EQ 50MG BASE A 071422 004 Nov 09, 1987 Aug CMS1 >A> AB EQ 75MG BASE A 071422 005 Nov 09, 1987 Aug CMS1 >A> AB EQ 150MG BASE A 071422 006 Nov 09, 1987 Aug CMS1

DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL;INJECTION DOXIL (LIPOSOMAL) >A> AB + BAXTER HLTHCARE CORP 20MG/10ML (2MG/ML) N 050718 001 Nov 17, 1995 Aug CAHN >A> AB + 50MG/25ML (2MG/ML) N 050718 002 Jun 13, 2000 Aug CAHN >D> AB + JANSSEN RES AND DEV 20MG/10ML (2MG/ML) N 050718 001 Nov 17, 1995 Aug CAHN >D> AB + 50MG/25ML (2MG/ML) N 050718 002 Jun 13, 2000 Aug CAHN

DOXYCYCLINE HYCLATE TABLET;ORAL DOXYCYCLINE HYCLATE >D> @ EPIC PHARMA LLC EQ 20MG BASE A 065182 001 May 13, 2005 Aug CMFD >A> AB EQ 20MG BASE A 065182 001 May 13, 2005 Aug CMFD

DROSPIRENONE; ETHINYL ESTRADIOL TABLET;ORAL DROSPIRENONE AND ETHINYL ESTRADIOL >A> AB ANDA REPOSITORY 3MG;0.02MG A 203291 001 Jul 18, 2017 Aug CAHN >D> AB PII 3MG;0.02MG A 203291 001 Jul 18, 2017 Aug CAHN LORYNA >D> AB LABS LEON FARMA 3MG;0.02MG A 079221 001 Mar 28, 2011 Aug CAHN >A> AB XIROMED 3MG;0.02MG A 079221 001 Mar 28, 2011 Aug CAHN TABLET;ORAL-28 SYEDA >D> AB LABS LEON FARMA 3MG;0.03MG A 090114 001 Mar 28, 2011 Aug CAHN >A> AB XIROMED 3MG;0.03MG A 090114 001 Mar 28, 2011 Aug CAHN

Page 7 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DULOXETINE HYDROCHLORIDE CAPSULE, DELAYED REL PELLETS;ORAL DULOXETINE HYDROCHLORIDE >A> AB INVENTIA EQ 20MG BASE A 202336 001 Oct 28, 2015 Aug CAHN >A> AB EQ 30MG BASE A 202336 002 Oct 28, 2015 Aug CAHN >A> AB EQ 60MG BASE A 202336 003 Oct 28, 2015 Aug CAHN >D> AB INVENTIA HLTHCARE EQ 20MG BASE A 202336 001 Oct 28, 2015 Aug CAHN >D> AB EQ 30MG BASE A 202336 002 Oct 28, 2015 Aug CAHN >D> AB EQ 60MG BASE A 202336 003 Oct 28, 2015 Aug CAHN >D> AB TEVA PHARMS USA EQ 20MG BASE A 090783 001 Dec 11, 2013 Aug DISC >A> @ EQ 20MG BASE A 090783 001 Dec 11, 2013 Aug DISC >D> AB EQ 30MG BASE A 090783 002 Dec 11, 2013 Aug DISC >A> @ EQ 30MG BASE A 090783 002 Dec 11, 2013 Aug DISC >D> AB EQ 60MG BASE A 090783 003 Dec 11, 2013 Aug DISC >A> @ EQ 60MG BASE A 090783 003 Dec 11, 2013 Aug DISC >A> AB YAOPHARMA CO LTD EQ 20MG BASE A 207219 001 Aug 16, 2019 Aug NEWA >A> AB EQ 30MG BASE A 207219 002 Aug 16, 2019 Aug NEWA >A> AB EQ 60MG BASE A 207219 003 Aug 16, 2019 Aug NEWA

EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE >D> AB LAURUS LABS LTD 200MG;300MG A 212114 001 Jul 26, 2019 Aug DISC >A> @ 200MG;300MG A 212114 001 Jul 26, 2019 Aug DISC

>A> ENTRECTINIB >A> CAPSULE;ORAL >A> ROZLYTREK >A> + GENENTECH INC 100MG N 212725 001 Aug 15, 2019 Aug NEWA >A> +! 200MG N 212725 002 Aug 15, 2019 Aug NEWA

EPINEPHRINE SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS ADRENALIN >D> AP +! PAR STERILE PRODUCTS EQ 1MG BASE/ML (EQ 1MG BASE/ML) N204200 001 Dec 07, 2012 Aug CTEC >A> +! EQ 1MG BASE/ML (EQ 1MG BASE/ML) N204200 001 Dec 07, 2012 Aug CTEC SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS >D> EPINEPHRINE >D> AP AM REGENT EQ 1MG BASE/ML (EQ 1MG BASE/ML) A207568 001 Jul 06, 2018 Aug DISC >A> @ EQ 1MG BASE/ML (EQ 1MG BASE/ML) A207568 001 Jul 06, 2018 Aug DISC

ERYTHROMYCIN SOLUTION;TOPICAL ERYTHRA-DERM >A> @ MLV 2% A 062687 001 Feb 05, 1988 Aug CAHN >D> @ SAPTALIS PHARMS 2% A 062687 001 Feb 05, 1988 Aug CAHN

>D> ESOMEPRAZOLE STRONTIUM >D> CAPSULE, DELAYED RELEASE;ORAL >D> ESOMEPRAZOLE STRONTIUM >D> +! R2 PHARMA LLC 49.3MG N 202342 002 Aug 06, 2013 Aug DISC >A> + @ 49.3MG N 202342 002 Aug 06, 2013 Aug DISC

ETHACRYNIC ACID TABLET;ORAL ETHACRYNIC ACID >A> AB LUPIN LTD 25MG A 211719 001 Sep 06, 2019 Aug NEWA >A> AB SCIEGEN PHARMS INC 25MG A 211232 001 Aug 27, 2019 Aug NEWA

ETHINYL ESTRADIOL; LEVONORGESTREL TABLET;ORAL INTROVALE >D> AB LABS LEON FARMA 0.03MG;0.15MG A 079064 001 Sep 27, 2010 Aug CAHN >A> AB XIROMED 0.03MG;0.15MG A 079064 001 Sep 27, 2010 Aug CAHN JAIMIESS >D> AB LABS LEON FARMA 0.03MG,0.01MG;0.15MG,N/A A 203770 001 Dec 27, 2017 Aug CAHN >A> AB XIROMED 0.03MG,0.01MG;0.15MG,N/A A 203770 001 Dec 27, 2017 Aug CAHN LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL >D> AB LABS LEON FARMA 0.02MG,0.1MG;0.01MG,N/A A 205131 001 Dec 14, 2017 Aug CAHN >A> AB XIROMED 0.02MG,0.1MG;0.01MG,N/A A 205131 001 Dec 14, 2017 Aug CAHN

Page 8 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ETHINYL ESTRADIOL; LEVONORGESTREL TABLET;ORAL-28 ALTAVERA >D> AB LABS LEON FARMA 0.03MG;0.15MG A 079102 001 Aug 03, 2010 Aug CAHN >A> AB XIROMED 0.03MG;0.15MG A 079102 001 Aug 03, 2010 Aug CAHN ELIFEMME >D> AB LABS LEON FARMA 0.03MG,0.04MG,0.03MG;0.05MG,0.0 A 202507 001 Dec 04, 2015 Aug CAHN 75MG,0.125MG >A> AB XIROMED 0.03MG,0.04MG,0.03MG;0.05MG,0.0 A 202507 001 Dec 04, 2015 Aug CAHN 75MG,0.125MG VIENVA >D> AB1 LABS LEON FARMA 0.02MG;0.1MG A 201088 001 May 21, 2015 Aug CAHN >A> AB1 XIROMED 0.02MG;0.1MG A 201088 001 May 21, 2015 Aug CAHN

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET, CHEWABLE;ORAL NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE >D> AB CHEMO RESEARCH SL 0.02MG;1MG A 209609 001 Jul 16, 2018 Aug CAHN >A> AB XIROMED 0.02MG;1MG A 209609 001 Jul 16, 2018 Aug CAHN

ETHINYL ESTRADIOL; NORGESTIMATE TABLET;ORAL-28 ESTARYLLA >D> AB LABS LEON FARMA 0.035MG;0.25MG A 090794 001 Jan 30, 2013 Aug CAHN >A> AB XIROMED 0.035MG;0.25MG A 090794 001 Jan 30, 2013 Aug CAHN TRI-ESTARYLLA >D> AB LABS LEON FARMA 0.035MG,0.035MG,0.035MG;0.18MG, A 090793 001 Jan 30, 2013 Aug CAHN 0.215MG,0.25MG >A> AB XIROMED 0.035MG,0.035MG,0.035MG;0.18MG, A 090793 001 Jan 30, 2013 Aug CAHN 0.215MG,0.25MG TRI-LO-ESTARYLLA >D> AB LABS LEON FARMA 0.025MG,0.025MG,0.025MG;0.18MG, A 091232 001 Jun 29, 2015 Aug CAHN 0.215MG,0.25MG >A> AB XIROMED 0.025MG,0.025MG,0.025MG;0.18MG, A 091232 001 Jun 29, 2015 Aug CAHN 0.215MG,0.25MG

FAMOTIDINE TABLET;ORAL FAMOTIDINE >A> AB CELLTRION 20MG A 075786 001 Apr 16, 2001 Aug CAHN >A> AB 40MG A 075786 002 Apr 16, 2001 Aug CAHN >D> AB WOCKHARDT LTD 20MG A 075786 001 Apr 16, 2001 Aug CAHN >D> AB 40MG A 075786 002 Apr 16, 2001 Aug CAHN

>A> FEDRATINIB HYDROCHLORIDE >A> CAPSULE;ORAL >A> INREBIC >A> +! IMPACT EQ 100MG BASE N 212327 001 Aug 16, 2019 Aug NEWA

FENOFIBRATE TABLET;ORAL FENOFIBRATE >A> AB APPCO PHARMA LLC 54MG A 210670 001 Sep 06, 2019 Aug NEWA >A> AB 160MG A 210670 002 Sep 06, 2019 Aug NEWA

FENTANYL FILM, EXTENDED RELEASE;TRANSDERMAL FENTANYL-100 >D> @ MAYNE PHARMA 100MCG/HR A 077062 004 Aug 20, 2007 Aug CMFD >A> AB 100MCG/HR A 077062 004 Aug 20, 2007 Aug CMFD FENTANYL-25 >D> @ MAYNE PHARMA 25MCG/HR A 077062 001 Aug 20, 2007 Aug CMFD >A> AB 25MCG/HR A 077062 001 Aug 20, 2007 Aug CMFD FENTANYL-50 >D> @ MAYNE PHARMA 50MCG/HR A 077062 002 Aug 20, 2007 Aug CMFD >A> AB 50MCG/HR A 077062 002 Aug 20, 2007 Aug CMFD FENTANYL-75 >D> @ MAYNE PHARMA 75MCG/HR A 077062 003 Aug 20, 2007 Aug CMFD >A> AB 75MCG/HR A 077062 003 Aug 20, 2007 Aug CMFD

Page 9 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

FEXOFENADINE HYDROCHLORIDE SUSPENSION;ORAL FEXOFENADINE HYDROCHLORIDE >D> @ ACTAVIS MID ATLANTIC 30MG/5ML A 201311 001 Jul 25, 2012 Aug CAHN >A> @ P AND L 30MG/5ML A 201311 001 Jul 25, 2012 Aug CAHN

FLUMAZENIL INJECTABLE;INJECTION FLUMAZENIL >D> AP HIKMA FARMACEUTICA 1MG/10ML (0.1MG/ML) A 078527 002 Mar 23, 2009 Aug CHRS >A> AP ! 1MG/10ML (0.1MG/ML) A 078527 002 Mar 23, 2009 Aug CHRS >D> AP ! MYLAN LABS LTD 1MG/10ML (0.1MG/ML) A 078595 002 May 13, 2008 Aug DISC >A> @ 1MG/10ML (0.1MG/ML) A 078595 002 May 13, 2008 Aug DISC

FLUOROURACIL CREAM;TOPICAL EFUDEX >A> AB +! BAUSCH 5% N 016831 003 Jul 29, 1970 Aug CAHN >D> AB +! VALEANT PHARM INTL 5% N 016831 003 Jul 29, 1970 Aug CAHN SOLUTION;TOPICAL EFUDEX >A> AT +! BAUSCH 2% N 016831 001 Jul 29, 1970 Aug CAHN >A> AT +! 5% N 016831 002 Jul 29, 1970 Aug CAHN >D> AT +! VALEANT PHARM INTL 2% N 016831 001 Jul 29, 1970 Aug CAHN >D> AT +! 5% N 016831 002 Jul 29, 1970 Aug CAHN

FLUOXETINE HYDROCHLORIDE CAPSULE;ORAL FLUOXETINE HYDROCHLORIDE >A> @ CELLTRION EQ 10MG BASE A 078143 001 Jan 16, 2008 Aug CAHN >A> @ EQ 20MG BASE A 078143 002 Jan 16, 2008 Aug CAHN >A> @ EQ 40MG BASE A 078143 003 Jan 16, 2008 Aug CAHN >D> @ WOCKHARDT LTD EQ 10MG BASE A 078143 001 Jan 16, 2008 Aug CAHN >D> @ EQ 20MG BASE A 078143 002 Jan 16, 2008 Aug CAHN >D> @ EQ 40MG BASE A 078143 003 Jan 16, 2008 Aug CAHN

FORMOTEROL FUMARATE; MOMETASONE FUROATE AEROSOL, METERED;INHALATION DULERA >A> + MERCK SHARP DOHME 0.005MG/INH;0.05MG/INH N 022518 003 Aug 12, 2019 Aug NEWA

FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS FOSAPREPITANT DIMEGLUMINE >A> AP APOTEX INC EQ 150MG BASE/VIAL A 205020 001 Sep 05, 2019 Aug NEWA >A> AP BAXTER HLTHCARE CORP EQ 150MG BASE/VIAL A 211860 001 Sep 05, 2019 Aug NEWA >A> AP BE PHARMS EQ 150MG BASE/VIAL A 212309 001 Sep 05, 2019 Aug NEWA >A> AP LUPIN LTD EQ 150MG BASE/VIAL A 210689 001 Sep 05, 2019 Aug NEWA >A> AP MSN LABS PVT LTD EQ 150MG BASE/VIAL A 209965 001 Sep 05, 2019 Aug NEWA >A> MYLAN LABS LTD EQ 115MG BASE/VIAL A 204015 001 Sep 05, 2019 Aug NFTG >A> AP EQ 150MG BASE/VIAL A 204015 002 Sep 05, 2019 Aug NEWA >A> AP SUNGEN PHARMA EQ 150MG BASE/VIAL A 211624 001 Sep 05, 2019 Aug NEWA

FROVATRIPTAN SUCCINATE TABLET;ORAL FROVATRIPTAN SUCCINATE >D> @ AMNEAL PHARMS CO EQ 2.5MG BASE A 211292 001 Nov 06, 2018 Aug CMFD >A> AB EQ 2.5MG BASE A 211292 001 Nov 06, 2018 Aug CMFD

FULVESTRANT INJECTABLE;INTRAMUSCULAR FULVESTRANT >A> AO GLENMARK PHARMS INC 50MG/ML A 207754 001 Aug 22, 2019 Aug NEWA >A> AO SAGENT PHARMS 50MG/ML A 205871 001 Aug 22, 2019 Aug NEWA SOLUTION;INTRAMUSCULAR FULVESTRANT >A> TEVA PHARMS USA INC 250MG/5ML (50MG/ML) N 210063 001 Aug 19, 2019 Aug NEWA

Page 10 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

GABAPENTIN TABLET;ORAL GABAPENTIN >D> AB APOTEX INC 600MG A 077661 004 Sep 13, 2006 Aug CAHN >D> AB 800MG A 077661 005 Sep 13, 2006 Aug CAHN >A> AB RUBICON 600MG A 077661 004 Sep 13, 2006 Aug CAHN >A> AB 800MG A 077661 005 Sep 13, 2006 Aug CAHN

>A> GALLIUM DOTATOC GA-68 >A> SOLUTION;INTRAVENOUS >A> GALLIUM DOTATOC GA 68 >A> +! UIHC PET IMAGING 0.5-4mCi/ML N 210828 001 Aug 21, 2019 Aug NEWA

GALLIUM NITRATE INJECTABLE;INJECTION GANITE >D> @ CHAPTER 7 TRUSTEE 25MG/ML N 019961 002 Jan 17, 1991 Aug CAHN >A> @ CHEPLAPHARM 25MG/ML N 019961 002 Jan 17, 1991 Aug CAHN

GANCICLOVIR SODIUM INJECTABLE;INJECTION CYTOVENE >A> AP +! CHEPLAPHARM EQ 500MG BASE/VIAL N 019661 001 Jun 23, 1989 Aug CAHN >D> AP +! ROCHE PALO EQ 500MG BASE/VIAL N 019661 001 Jun 23, 1989 Aug CAHN

GLYBURIDE; METFORMIN HYDROCHLORIDE TABLET;ORAL GLYBURIDE AND METFORMIN HYDROCHLORIDE >D> AB HERITAGE PHARMS INC 1.25MG;250MG A 079009 001 Jun 03, 2009 Aug DISC >A> @ 1.25MG;250MG A 079009 001 Jun 03, 2009 Aug DISC >D> AB 2.5MG;500MG A 079009 002 Jun 03, 2009 Aug DISC >A> @ 2.5MG;500MG A 079009 002 Jun 03, 2009 Aug DISC >D> AB 5MG;500MG A 079009 003 Jun 03, 2009 Aug DISC >A> @ 5MG;500MG A 079009 003 Jun 03, 2009 Aug DISC

GLYCOPYRROLATE INJECTABLE;INJECTION ROBINUL >A> + @ HIKMA 0.2MG/ML N 017558 001 Feb 06, 1975 Aug CAHN >D> + @ WEST-WARD PHARMS INT 0.2MG/ML N 017558 001 Feb 06, 1975 Aug CAHN

HALCINONIDE CREAM;TOPICAL HALOG >D> +! SUN PHARM INDS INC 0.1% N 017556 001 Nov 27, 1974 Aug CFTG >A> AB +! 0.1% N 017556 001 Nov 27, 1974 Aug CFTG

HEPARIN SODIUM INJECTABLE;INJECTION HEPARIN SODIUM >A> B BRAUN MEDICAL INC 5,000 UNITS/0.5ML A 208827 001 Nov 19, 2018 Aug CAHN >D> STERINOVA INC 5,000 UNITS/0.5ML A 208827 001 Nov 19, 2018 Aug CAHN

HYDROCHLOROTHIAZIDE; LISINOPRIL TABLET;ORAL LISINOPRIL AND HYDROCHLOROTHIAZIDE >D> AB HERITAGE PHARMA 12.5MG;10MG A 075776 001 Jul 01, 2002 Aug DISC >A> @ 12.5MG;10MG A 075776 001 Jul 01, 2002 Aug DISC >D> AB 12.5MG;20MG A 075776 002 Jul 01, 2002 Aug DISC >A> @ 12.5MG;20MG A 075776 002 Jul 01, 2002 Aug DISC >D> AB 25MG;20MG A 075776 003 Jul 01, 2002 Aug DISC >A> @ 25MG;20MG A 075776 003 Jul 01, 2002 Aug DISC

HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL TABLET;ORAL OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE >D> AB ACCORD HLTHCARE 12.5MG;20MG A 209281 001 Feb 07, 2019 Aug DISC >A> @ 12.5MG;20MG A 209281 001 Feb 07, 2019 Aug DISC >D> AB 12.5MG;40MG A 209281 002 Feb 07, 2019 Aug DISC >A> @ 12.5MG;40MG A 209281 002 Feb 07, 2019 Aug DISC >D> AB 25MG;40MG A 209281 003 Feb 07, 2019 Aug DISC

Page 11 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL TABLET;ORAL OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE >A> @ 25MG;40MG A 209281 003 Feb 07, 2019 Aug DISC

HYDROCHLOROTHIAZIDE; VALSARTAN TABLET;ORAL VALSARTAN AND HYDROCHLOROTHIAZIDE >D> AB ZYDUS PHARMS 12.5MG;80MG A 203000 001 Mar 15, 2019 Aug DISC >A> @ 12.5MG;80MG A 203000 001 Mar 15, 2019 Aug DISC >D> AB 12.5MG;160MG A 203000 002 Mar 15, 2019 Aug DISC >A> @ 12.5MG;160MG A 203000 002 Mar 15, 2019 Aug DISC >D> AB 12.5MG;320MG A 203000 003 Mar 15, 2019 Aug DISC >A> @ 12.5MG;320MG A 203000 003 Mar 15, 2019 Aug DISC >D> AB 25MG;160MG A 203000 004 Mar 15, 2019 Aug DISC >A> @ 25MG;160MG A 203000 004 Mar 15, 2019 Aug DISC >D> AB 25MG;320MG A 203000 005 Mar 15, 2019 Aug DISC >A> @ 25MG;320MG A 203000 005 Mar 15, 2019 Aug DISC

HYDROCORTISONE TABLET;ORAL HYDROCORTISONE >A> AB BRECKENRIDGE 5MG A 207029 001 Apr 27, 2017 Aug CAHN >A> AB 10MG A 207029 002 Apr 27, 2017 Aug CAHN >A> AB 20MG A 207029 003 Apr 27, 2017 Aug CAHN >D> AB PII 5MG A 207029 001 Apr 27, 2017 Aug CAHN >D> AB 10MG A 207029 002 Apr 27, 2017 Aug CAHN >D> AB 20MG A 207029 003 Apr 27, 2017 Aug CAHN

HYDROCORTISONE VALERATE CREAM;TOPICAL HYDROCORTISONE VALERATE >A> AB LUPIN LTD 0.2% A 210307 001 Aug 15, 2019 Aug NEWA

>D> HYDROGEN PEROXIDE >D> SOLUTION;TOPICAL >D> ESKATA >D> +! ACLARIS 40% N 209305 001 Dec 14, 2017 Aug DISC >A> + @ 40% N 209305 001 Dec 14, 2017 Aug DISC

HYDROXYZINE HYDROCHLORIDE TABLET;ORAL HYDROXYZINE HYDROCHLORIDE >D> AB MYLAN 10MG A 091176 001 Jun 07, 2010 Aug DISC >A> @ 10MG A 091176 001 Jun 07, 2010 Aug DISC >D> AB 25MG A 091176 002 Jun 07, 2010 Aug DISC >A> @ 25MG A 091176 002 Jun 07, 2010 Aug DISC >D> AB 50MG A 091176 003 Jun 07, 2010 Aug DISC >A> @ 50MG A 091176 003 Jun 07, 2010 Aug DISC

ILOPERIDONE TABLET;ORAL FANAPT >D> AB +! VANDA PHARMS INC 1MG N 022192 001 May 06, 2009 Aug CTEC >A> +! 1MG N 022192 001 May 06, 2009 Aug CTEC >D> AB + 2MG N 022192 002 May 06, 2009 Aug CTEC >A> + 2MG N 022192 002 May 06, 2009 Aug CTEC >D> AB + 4MG N 022192 003 May 06, 2009 Aug CTEC >A> + 4MG N 022192 003 May 06, 2009 Aug CTEC >D> AB + 6MG N 022192 004 May 06, 2009 Aug CTEC >A> + 6MG N 022192 004 May 06, 2009 Aug CTEC >D> AB + 8MG N 022192 005 May 06, 2009 Aug CTEC >A> + 8MG N 022192 005 May 06, 2009 Aug CTEC >D> AB + 10MG N 022192 006 May 06, 2009 Aug CTEC >A> + 10MG N 022192 006 May 06, 2009 Aug CTEC >D> AB + 12MG N 022192 007 May 06, 2009 Aug CTEC >A> + 12MG N 022192 007 May 06, 2009 Aug CTEC ILOPERIDONE >A> @ INVENTIA 1MG A 207231 001 Nov 28, 2016 Aug CAHN >A> @ 2MG A 207231 002 Nov 28, 2016 Aug CAHN

Page 12 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ILOPERIDONE TABLET;ORAL ILOPERIDONE >A> @ 4MG A 207231 003 Nov 28, 2016 Aug CAHN >A> @ 6MG A 207231 004 Nov 28, 2016 Aug CAHN >A> @ 8MG A 207231 005 Nov 28, 2016 Aug CAHN >A> @ 10MG A 207231 006 Nov 28, 2016 Aug CAHN >A> @ 12MG A 207231 007 Nov 28, 2016 Aug CAHN >D> @ INVENTIA HLTHCARE 1MG A 207231 001 Nov 28, 2016 Aug CAHN >D> @ 2MG A 207231 002 Nov 28, 2016 Aug CAHN >D> @ 4MG A 207231 003 Nov 28, 2016 Aug CAHN >D> @ 6MG A 207231 004 Nov 28, 2016 Aug CAHN >D> @ 8MG A 207231 005 Nov 28, 2016 Aug CAHN >D> @ 10MG A 207231 006 Nov 28, 2016 Aug CAHN >D> @ 12MG A 207231 007 Nov 28, 2016 Aug CAHN >D> AB TARO PHARM INDS LTD 1MG A 207098 001 Jul 22, 2019 Aug DISC >A> @ 1MG A 207098 001 Jul 22, 2019 Aug DISC >D> AB 2MG A 207098 002 Jul 22, 2019 Aug DISC >A> @ 2MG A 207098 002 Jul 22, 2019 Aug DISC >D> AB 4MG A 207098 003 Jul 22, 2019 Aug DISC >A> @ 4MG A 207098 003 Jul 22, 2019 Aug DISC >D> AB 6MG A 207098 004 Jul 22, 2019 Aug DISC >A> @ 6MG A 207098 004 Jul 22, 2019 Aug DISC >D> AB 8MG A 207098 005 Jul 22, 2019 Aug DISC >A> @ 8MG A 207098 005 Jul 22, 2019 Aug DISC >D> AB 10MG A 207098 006 Jul 22, 2019 Aug DISC >A> @ 10MG A 207098 006 Jul 22, 2019 Aug DISC >D> AB 12MG A 207098 007 Jul 22, 2019 Aug DISC >A> @ 12MG A 207098 007 Jul 22, 2019 Aug DISC

IMATINIB MESYLATE TABLET;ORAL IMATINIB MESYLATE >D> AB AMNEAL PHARMS EQ 100MG BASE A 207495 001 Feb 08, 2019 Aug DISC >A> @ EQ 100MG BASE A 207495 001 Feb 08, 2019 Aug DISC >D> AB EQ 400MG BASE A 207495 002 Feb 08, 2019 Aug DISC >A> @ EQ 400MG BASE A 207495 002 Feb 08, 2019 Aug DISC

IMIQUIMOD CREAM;TOPICAL ALDARA >A> AB +! BAUSCH 5% N 020723 001 Feb 27, 1997 Aug CAHN >D> AB +! MEDICIS 5% N 020723 001 Feb 27, 1997 Aug CAHN ZYCLARA >A> +! BAUSCH 2.5% N 022483 002 Jul 15, 2011 Aug CAHN >A> +! 3.75% N 022483 001 Mar 25, 2010 Aug CAHN >D> +! MEDICIS 2.5% N 022483 002 Jul 15, 2011 Aug CAHN >D> +! 3.75% N 022483 001 Mar 25, 2010 Aug CAHN

INDOMETHACIN CAPSULE;ORAL INDOMETHACIN >D> AB GLENMARK GENERICS 50MG A 091276 002 Dec 22, 2010 Aug CHRS >A> AB ! 50MG A 091276 002 Dec 22, 2010 Aug CHRS >D> AB MYLAN 25MG N 018858 001 Apr 20, 1984 Aug DISC >A> @ 25MG N 018858 001 Apr 20, 1984 Aug DISC >D> AB ! 50MG A 070624 001 Sep 04, 1985 Aug DISC >A> @ 50MG A 070624 001 Sep 04, 1985 Aug DISC

IOPROMIDE INJECTABLE;INJECTION ULTRAVIST (PHARMACY BULK) >D> +! BAYER HLTHCARE 49.9% N 021425 003 Mar 12, 2004 Aug DISC >A> + @ 49.9% N 021425 003 Mar 12, 2004 Aug DISC >D> ULTRAVIST 240 >D> +! BAYER HLTHCARE 49.9% N 020220 003 May 10, 1995 Aug DISC >A> + @ 49.9% N 020220 003 May 10, 1995 Aug DISC

Page 13 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ISONIAZID TABLET;ORAL ISONIAZID >D> AA BARR 100MG A 080936 001 Aug 24, 1972 Aug CHRS >A> AA ! 100MG A 080936 001 Aug 24, 1972 Aug CHRS >D> AA 300MG A 080937 002 Oct 24, 1974 Aug CHRS >A> AA ! 300MG A 080937 002 Oct 24, 1974 Aug CHRS >D> AA +! SANDOZ 100MG N 008678 002 Nov 17, 1952 Aug DISC >A> + @ 100MG N 008678 002 Nov 17, 1952 Aug DISC >D> AA +! 300MG N 008678 003 Sep 30, 1980 Aug DISC >A> + @ 300MG N 008678 003 Sep 30, 1980 Aug DISC

>A> ISTRADEFYLLINE >A> TABLET;ORAL >A> NOURIANZ >A> + KYOWA KIRIN 20MG N 022075 001 Aug 27, 2019 Aug NEWA >A> +! 40MG N 022075 002 Aug 27, 2019 Aug NEWA

ITRACONAZOLE CAPSULE;ORAL ITRACONAZOLE >A> AB ANDA REPOSITORY 100MG A 206410 001 Jul 02, 2019 Aug CAHN >D> AB PII 100MG A 206410 001 Jul 02, 2019 Aug CAHN

LACTULOSE SOLUTION;ORAL LACTULOSE >D> @ XTTRIUM LABS INC 10GM/15ML A 075911 001 Feb 21, 2002 Aug CMFD >A> AA 10GM/15ML A 075911 001 Feb 21, 2002 Aug CMFD

LAMIVUDINE; ZIDOVUDINE TABLET;ORAL LAMIVUDINE AND ZIDOVUDINE >D> AB MYLAN 150MG;300MG A 079079 001 Aug 12, 2019 Aug DISC >A> @ 150MG;300MG A 079079 001 Aug 12, 2019 Aug DISC

LAMOTRIGINE TABLET;ORAL LAMOTRIGINE >A> @ CELLTRION 25MG A 078982 001 Jan 27, 2009 Aug CAHN >A> @ 100MG A 078982 002 Jan 27, 2009 Aug CAHN >A> @ 150MG A 078982 003 Jan 27, 2009 Aug CAHN >A> @ 200MG A 078982 004 Jan 27, 2009 Aug CAHN >D> @ WOCKHARDT 25MG A 078982 001 Jan 27, 2009 Aug CAHN >D> @ 100MG A 078982 002 Jan 27, 2009 Aug CAHN >D> @ 150MG A 078982 003 Jan 27, 2009 Aug CAHN >D> @ 200MG A 078982 004 Jan 27, 2009 Aug CAHN

LANSOPRAZOLE CAPSULE, DELAYED REL PELLETS;ORAL LANSOPRAZOLE >A> AB INVENTIA 15MG A 205868 001 Aug 30, 2017 Aug CAHN >A> AB 30MG A 205868 002 Aug 30, 2017 Aug CAHN >D> AB INVENTIA HLTHCARE 15MG A 205868 001 Aug 30, 2017 Aug CAHN >D> AB 30MG A 205868 002 Aug 30, 2017 Aug CAHN >D> AB LABS LICONSA 15MG A 203203 001 Jul 25, 2016 Aug CAHN >D> AB 30MG A 203203 002 Jul 25, 2016 Aug CAHN >A> AB XIROMED 15MG A 203203 001 Jul 25, 2016 Aug CAHN >A> AB 30MG A 203203 002 Jul 25, 2016 Aug CAHN

LATANOPROST SOLUTION/DROPS;OPHTHALMIC LATANOPROST >A> AT AUROBINDO PHARMA LTD 0.005% A 206519 001 Sep 03, 2019 Aug NEWA

Page 14 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

>A> LEDIPASVIR; SOFOSBUVIR >A> PELLETS;ORAL >A> HARVONI >A> + GILEAD SCIENCES INC 33.75MG;150MG/PACKET N 212477 001 Aug 28, 2019 Aug NEWA >A> +! 45MG;200MG/PACKET N 212477 002 Aug 28, 2019 Aug NEWA TABLET;ORAL HARVONI >A> + GILEAD SCIENCES INC 45MG;200MG N 205834 002 Aug 28, 2019 Aug NEWA

>A> LEFAMULIN ACETATE >A> SOLUTION;INTRAVENOUS >A> XENLETA >A> +! NABRIVA EQ 150MG BASE/15ML (EQ 10MG N 211673 001 Aug 19, 2019 Aug NEWA BASE/ML) >A> TABLET;ORAL >A> XENLETA >A> +! NABRIVA EQ 600MG BASE N 211672 001 Aug 19, 2019 Aug NEWA

LEVETIRACETAM INJECTABLE;INTRAVENOUS LEVETIRACETAM >D> AP AKORN 500MG/5ML (100MG/ML) A 209934 001 May 04, 2018 Aug DISC >A> @ 500MG/5ML (100MG/ML) A 209934 001 May 04, 2018 Aug DISC SOLUTION;ORAL LEVETIRACETAM >A> AA ANDA REPOSITORY 100MG/ML A 079107 001 Jan 15, 2009 Aug CAHN >D> AA TOLMAR 100MG/ML A 079107 001 Jan 15, 2009 Aug CAHN

LEVOFLOXACIN TABLET;ORAL LEVOFLOXACIN >A> AB CELLTRION 250MG A 090367 001 Jun 20, 2011 Aug CAHN >A> AB 500MG A 090367 002 Jun 20, 2011 Aug CAHN >A> AB 750MG A 090367 003 Jun 20, 2011 Aug CAHN >D> AB WOCKHARDT 250MG A 090367 001 Jun 20, 2011 Aug CAHN >D> AB 500MG A 090367 002 Jun 20, 2011 Aug CAHN >D> AB 750MG A 090367 003 Jun 20, 2011 Aug CAHN

LEVOLEUCOVORIN CALCIUM POWDER;INTRAVENOUS LEVOLEUCOVORIN CALCIUM >A> AP NANJING KING-FRIEND EQ 50MG BASE/VIAL A 211003 001 Aug 22, 2019 Aug NEWA SOLUTION;INTRAVENOUS LEVOLEUCOVORIN CALCIUM >D> AP MYLAN TEORANTA EQ 175MG BASE/17.5ML (EQ 10MG A 203576 001 Oct 20, 2015 Aug DISC BASE/ML) >A> @ EQ 175MG BASE/17.5ML (EQ 10MG A 203576 001 Oct 20, 2015 Aug DISC BASE/ML) >D> AP EQ 250MG BASE/25ML (EQ 10MG A 203576 002 Oct 20, 2015 Aug DISC BASE/ML) >A> @ EQ 250MG BASE/25ML (EQ 10MG A 203576 002 Oct 20, 2015 Aug DISC BASE/ML) >A> AP NANJING KING-FRIEND EQ 175MG BASE/17.5ML (EQ 10MG A 211002 001 Aug 16, 2019 Aug NEWA BASE/ML) >A> AP EQ 250MG BASE/25ML (EQ 10MG A 211002 002 Aug 16, 2019 Aug NEWA BASE/ML)

LIDOCAINE HYDROCHLORIDE SOLUTION;ORAL XYLOCAINE VISCOUS >D> @ FRESENIUS KABI USA 2% N 009470 001 Sep 02, 1954 Aug CRLD >A> + @ 2% N 009470 001 Sep 02, 1954 Aug CRLD

LISINOPRIL TABLET;ORAL LISINOPRIL >D> AB HERITAGE PHARMA 2.5MG A 075752 001 Jul 01, 2002 Aug DISC >A> @ 2.5MG A 075752 001 Jul 01, 2002 Aug DISC >D> AB 5MG A 075752 002 Jul 01, 2002 Aug DISC >A> @ 5MG A 075752 002 Jul 01, 2002 Aug DISC >D> AB 10MG A 075752 003 Jul 01, 2002 Aug DISC >A> @ 10MG A 075752 003 Jul 01, 2002 Aug DISC

Page 15 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

LISINOPRIL TABLET;ORAL LISINOPRIL >D> AB 20MG A 075752 004 Jul 01, 2002 Aug DISC >A> @ 20MG A 075752 004 Jul 01, 2002 Aug DISC >D> AB 30MG A 075752 005 Jul 01, 2002 Aug DISC >A> @ 30MG A 075752 005 Jul 01, 2002 Aug DISC >D> AB 40MG A 075752 006 Jul 01, 2002 Aug DISC >A> @ 40MG A 075752 006 Jul 01, 2002 Aug DISC >D> AB MYLAN 2.5MG A 076071 001 Jul 01, 2002 Aug DISC >A> @ 2.5MG A 076071 001 Jul 01, 2002 Aug DISC >D> AB 5MG A 076071 002 Jul 01, 2002 Aug DISC >A> @ 5MG A 076071 002 Jul 01, 2002 Aug DISC >D> AB 10MG A 076071 003 Jul 01, 2002 Aug DISC >A> @ 10MG A 076071 003 Jul 01, 2002 Aug DISC >D> AB 20MG A 076071 004 Jul 01, 2002 Aug DISC >A> @ 20MG A 076071 004 Jul 01, 2002 Aug DISC >D> AB 30MG A 076071 005 Jul 01, 2002 Aug DISC >A> @ 30MG A 076071 005 Jul 01, 2002 Aug DISC >D> AB 40MG A 076071 006 Jul 01, 2002 Aug DISC >A> @ 40MG A 076071 006 Jul 01, 2002 Aug DISC

LOXAPINE POWDER;INHALATION ADASUVE >A> +! ALEXZA PHARMS 10MG N 022549 001 Dec 21, 2012 Aug CAHN >D> +! GALEN UK 10MG N 022549 001 Dec 21, 2012 Aug CAHN

LURASIDONE HYDROCHLORIDE TABLET;ORAL LURASIDONE HYDROCHLORIDE >A> AB EMCURE PHARMS LTD 20MG A 208058 001 Sep 04, 2019 Aug NEWA >A> AB 40MG A 208058 002 Sep 04, 2019 Aug NEWA >A> AB 60MG A 208058 003 Sep 04, 2019 Aug NEWA >A> AB 80MG A 208058 004 Sep 04, 2019 Aug NEWA >D> AB ZYDUS PHARMS 20MG A 208052 001 Mar 19, 2019 Aug DISC >A> @ 20MG A 208052 001 Mar 19, 2019 Aug DISC >D> AB 40MG A 208052 002 Mar 19, 2019 Aug DISC >A> @ 40MG A 208052 002 Mar 19, 2019 Aug DISC >D> AB 60MG A 208052 003 Mar 19, 2019 Aug DISC >A> @ 60MG A 208052 003 Mar 19, 2019 Aug DISC >D> AB 80MG A 208052 004 Mar 19, 2019 Aug DISC >A> @ 80MG A 208052 004 Mar 19, 2019 Aug DISC >D> AB 120MG A 208052 005 Mar 19, 2019 Aug DISC >A> @ 120MG A 208052 005 Mar 19, 2019 Aug DISC

MALATHION LOTION;TOPICAL MALATHION >D> AT SUVEN LIFE 0.5% A 091559 001 May 23, 2012 Aug CTEC >A> 0.5% A 091559 001 May 23, 2012 Aug CTEC >A> ! 0.5% A 091559 001 May 23, 2012 Aug CHRS >D> OVIDE >D> AT +! TARO PHARM INDS LTD 0.5% N 018613 001 Aug 02, 1982 Aug DISC >A> + @ 0.5% N 018613 001 Aug 02, 1982 Aug DISC

MEMANTINE HYDROCHLORIDE TABLET;ORAL MEMANTINE HYDROCHLORIDE >A> AB CELLTRION 5MG A 090073 001 Sep 04, 2015 Aug CAHN >A> AB 10MG A 090073 002 Sep 04, 2015 Aug CAHN >D> AB WOCKHARDT LTD 5MG A 090073 001 Sep 04, 2015 Aug CAHN >D> AB 10MG A 090073 002 Sep 04, 2015 Aug CAHN

MEPERIDINE HYDROCHLORIDE TABLET;ORAL >D> DEMEROL >D> AA +! US PHARM HOLDINGS 50MG N 005010 001 Nov 10, 1942 Aug DISC >A> + @ 50MG N 005010 001 Nov 10, 1942 Aug DISC >D> AA +! 100MG N 005010 004 Sep 25, 1947 Aug DISC

Page 16 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

MEPERIDINE HYDROCHLORIDE TABLET;ORAL DEMEROL >A> + @ 100MG N 005010 004 Sep 25, 1947 Aug DISC MEPERIDINE HYDROCHLORIDE >D> AA MIKART 50MG A 040893 001 Jun 24, 2009 Aug DISC >A> @ 50MG A 040893 001 Jun 24, 2009 Aug DISC >D> 75MG A 040893 002 Jun 24, 2009 Aug DISC >A> @ 75MG A 040893 002 Jun 24, 2009 Aug DISC >D> AA 100MG A 040893 003 Jun 24, 2009 Aug DISC >A> @ 100MG A 040893 003 Jun 24, 2009 Aug DISC >D> 150MG A 040893 004 Jun 24, 2009 Aug DISC >A> @ 150MG A 040893 004 Jun 24, 2009 Aug DISC >D> AA SPECGX LLC 50MG A 040352 001 Jun 13, 2000 Aug DISC >A> @ 50MG A 040352 001 Jun 13, 2000 Aug DISC >D> AA 100MG A 040352 002 Jun 13, 2000 Aug DISC >A> @ 100MG A 040352 002 Jun 13, 2000 Aug DISC >D> AA WEST-WARD PHARMS INT 50MG A 040110 001 Mar 12, 1997 Aug CHRS >A> AA ! 50MG A 040110 001 Mar 12, 1997 Aug CHRS >D> AA 100MG A 040110 002 Mar 12, 1997 Aug CHRS >A> AA ! 100MG A 040110 002 Mar 12, 1997 Aug CHRS

MEROPENEM INJECTABLE;INJECTION MEROPENEM >A> AP HQ SPCLT PHARMA 500MG/VIAL A 210773 001 Aug 16, 2019 Aug NEWA >A> AP 1GM/VIAL A 210773 002 Aug 16, 2019 Aug NEWA

MESALAMINE TABLET, DELAYED RELEASE;ORAL MESALAMINE >D> AB SUN PHARM 1.2GM A 211858 001 Jan 25, 2019 Aug DISC >A> @ 1.2GM A 211858 001 Jan 25, 2019 Aug DISC

METFORMIN HYDROCHLORIDE >A> FOR SUSPENSION, EXTENDED RELEASE;ORAL >A> RIOMET ER >A> +! SUN PHARM 500MG/5ML N 212595 001 Aug 29, 2019 Aug NEWA TABLET, EXTENDED RELEASE;ORAL METFORMIN HYDROCHLORIDE >A> AB1 INVENTIA 500MG A 201991 001 Jan 18, 2012 Aug CAHN >D> AB1 INVENTIA HLTHCARE 500MG A 201991 001 Jan 18, 2012 Aug CAHN

METHADONE HYDROCHLORIDE CONCENTRATE;ORAL METHADONE HYDROCHLORIDE >A> AA PHARM ASSOC 10MG/ML A 207368 001 Aug 22, 2019 Aug NEWA

METHOXSALEN CAPSULE;ORAL OXSORALEN-ULTRA >A> AB +! BAUSCH 10MG N 019600 001 Oct 30, 1986 Aug CAHN >D> AB +! DOW PHARM 10MG N 019600 001 Oct 30, 1986 Aug CAHN

METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL METHYLPHENIDATE HYDROCHLORIDE >A> AB ASCENT PHARMS INC 18MG A 211009 001 Sep 03, 2019 Aug NEWA >A> AB 27MG A 211009 002 Sep 03, 2019 Aug NEWA >A> AB 36MG A 211009 003 Sep 03, 2019 Aug NEWA >A> AB 54MG A 211009 004 Sep 03, 2019 Aug NEWA TABLET;ORAL METHYLPHENIDATE HYDROCHLORIDE >D> AB CEDIPROF INC 5MG A 208737 001 Feb 01, 2019 Aug DISC >A> @ 5MG A 208737 001 Feb 01, 2019 Aug DISC >D> AB 10MG A 208737 002 Feb 01, 2019 Aug DISC >A> @ 10MG A 208737 002 Feb 01, 2019 Aug DISC >D> AB 20MG A 208737 003 Feb 01, 2019 Aug DISC >A> @ 20MG A 208737 003 Feb 01, 2019 Aug DISC

Page 17 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

>D> METIPRANOLOL HYDROCHLORIDE >D> SOLUTION/DROPS;OPHTHALMIC >D> OPTIPRANOLOL >D> +! BAUSCH AND LOMB 0.3% N 019907 001 Dec 29, 1989 Aug DISC >A> + @ 0.3% N 019907 001 Dec 29, 1989 Aug DISC

MIDODRINE HYDROCHLORIDE TABLET;ORAL MIDODRINE HYDROCHLORIDE >A> AB RUBICON 2.5MG A 212543 001 Aug 19, 2019 Aug NEWA >A> AB 5MG A 212543 002 Aug 19, 2019 Aug NEWA >A> AB 10MG A 212543 003 Aug 19, 2019 Aug NEWA

MINOCYCLINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL XIMINO >A> SUN PHARM INDS INC EQ 45MG BASE N 201922 001 Jul 11, 2012 Aug CAHN >A> @ EQ 67.5MG BASE N 201922 002 Jul 11, 2012 Aug CAHN >A> EQ 90MG BASE N 201922 003 Jul 11, 2012 Aug CAHN >A> @ EQ 112.5MG BASE N 201922 004 Jul 11, 2012 Aug CAHN >A> EQ 135MG BASE N 201922 005 Jul 11, 2012 Aug CAHN >D> SUN PHARM INDS LTD EQ 45MG BASE N 201922 001 Jul 11, 2012 Aug CAHN >D> @ EQ 67.5MG BASE N 201922 002 Jul 11, 2012 Aug CAHN >D> EQ 90MG BASE N 201922 003 Jul 11, 2012 Aug CAHN >D> @ EQ 112.5MG BASE N 201922 004 Jul 11, 2012 Aug CAHN >D> EQ 135MG BASE N 201922 005 Jul 11, 2012 Aug CAHN TABLET, EXTENDED RELEASE;ORAL MINOCYCLINE HYDROCHLORIDE >A> AB AUROBINDO PHARMA LTD EQ 55MG BASE A 202261 008 Aug 21, 2019 Aug NEWA >A> @ MYLAN EQ 55MG BASE A 203443 001 Aug 21, 2019 Aug NEWA >D> AB MYLAN LABS LTD EQ 65MG BASE A 201467 001 Jul 30, 2019 Aug DISC >A> @ EQ 65MG BASE A 201467 001 Jul 30, 2019 Aug DISC >D> AB EQ 115MG BASE A 201467 002 Jul 30, 2019 Aug DISC >A> @ EQ 115MG BASE A 201467 002 Jul 30, 2019 Aug DISC

MODAFINIL TABLET;ORAL MODAFINIL >D> @ CADILA 100MG A 209966 001 Sep 14, 2017 Aug CMFD >A> AB 100MG A 209966 001 Sep 14, 2017 Aug CMFD >D> @ 200MG A 209966 002 Sep 14, 2017 Aug CMFD >A> AB 200MG A 209966 002 Sep 14, 2017 Aug CMFD >D> AB HIKMA PHARMS 100MG A 090543 001 Sep 26, 2012 Aug DISC >A> @ 100MG A 090543 001 Sep 26, 2012 Aug DISC >D> AB 200MG A 090543 002 Sep 26, 2012 Aug DISC >A> @ 200MG A 090543 002 Sep 26, 2012 Aug DISC

MOMETASONE FUROATE AEROSOL, METERED;INHALATION ASMANEX HFA >A> + MERCK SHARP DOHME 0.05MG/INH N 205641 003 Aug 12, 2019 Aug NEWA CREAM;TOPICAL >D> ELOCON >D> AB +! MERCK SHARP DOHME 0.1% N 019625 002 Apr 19, 2013 Aug DISC >A> + @ 0.1% N 019625 002 Apr 19, 2013 Aug DISC MOMETASONE FUROATE >D> AB GLENMARK GENERICS 0.1% A 078541 001 May 28, 2008 Aug CHRS >A> AB ! 0.1% A 078541 001 May 28, 2008 Aug CHRS

MORPHINE SULFATE INJECTABLE;INJECTION MITIGO >D> AP PIRAMAL CRITICAL 10MG/ML A 204393 001 Jul 16, 2018 Aug CAHN >A> AP 10MG/ML A 204393 001 Jul 16, 2018 Aug CAHN >D> AP 25MG/ML A 204393 002 Jul 16, 2018 Aug CAHN >A> AP 25MG/ML A 204393 002 Jul 16, 2018 Aug CAHN TABLET, EXTENDED RELEASE;ORAL MORPHINE SULFATE >D> AB MYLAN PHARMS INC 15MG A 200824 001 Oct 18, 2011 Aug DISC >A> @ 15MG A 200824 001 Oct 18, 2011 Aug DISC

Page 18 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL MORPHINE SULFATE >D> AB 30MG A 200824 002 Oct 18, 2011 Aug DISC >A> @ 30MG A 200824 002 Oct 18, 2011 Aug DISC >D> AB 60MG A 200824 003 Oct 18, 2011 Aug DISC >A> @ 60MG A 200824 003 Oct 18, 2011 Aug DISC >D> AB 100MG A 200824 004 Oct 18, 2011 Aug DISC >A> @ 100MG A 200824 004 Oct 18, 2011 Aug DISC

MYCOPHENOLATE MOFETIL TABLET;ORAL MYCOPHENOLATE MOFETIL >D> AB OXFORD PHARMS 500MG A 090606 001 Jul 16, 2010 Aug DISC >A> @ 500MG A 090606 001 Jul 16, 2010 Aug DISC

NABUMETONE TABLET;ORAL NABUMETONE >A> AB NEXGEN PHARMA INC 500MG A 203166 001 Aug 30, 2019 Aug NEWA >A> AB 750MG A 203166 002 Aug 30, 2019 Aug NEWA >A> 1GM A 203166 003 Aug 30, 2019 Aug NEWA

>D> NESIRITIDE RECOMBINANT >D> FOR SOLUTION;INTRAVENOUS >D> NATRECOR >D> +! SCIOS LLC 1.5MG/VIAL N 020920 001 Aug 10, 2001 Aug DISC >A> + @ 1.5MG/VIAL N 020920 001 Aug 10, 2001 Aug DISC

NITISINONE CAPSULE;ORAL >A> NITISINONE >A> AB NOVITIUM PHARMA 2MG A 211041 001 Aug 26, 2019 Aug NFTG >A> AB 5MG A 211041 002 Aug 26, 2019 Aug NFTG >A> AB 10MG A 211041 003 Aug 26, 2019 Aug NFTG ORFADIN >D> + SWEDISH ORPHAN 2MG N 021232 001 Jan 18, 2002 Aug CFTG >A> AB + 2MG N 021232 001 Jan 18, 2002 Aug CFTG >D> + 5MG N 021232 002 Jan 18, 2002 Aug CFTG >A> AB + 5MG N 021232 002 Jan 18, 2002 Aug CFTG >D> + 10MG N 021232 003 Jan 18, 2002 Aug CFTG >A> AB + 10MG N 021232 003 Jan 18, 2002 Aug CFTG

OFLOXACIN SOLUTION/DROPS;OTIC OFLOXACIN >A> AT AMNEAL PHARMS CO 0.3% A 211525 001 Aug 30, 2019 Aug NEWA

OLIVE OIL; SOYBEAN OIL EMULSION;INTRAVENOUS CLINOLIPID 20% >D> + @ BAXTER HLTHCARE CORP 16%(160GM/1000ML);4% N 204508 001 Oct 03, 2013 Aug CMFD (40GM/1000ML) >A> +! 16%(160GM/1000ML);4% N 204508 001 Oct 03, 2013 Aug CMFD (40GM/1000ML)

ONDANSETRON HYDROCHLORIDE INJECTABLE;INJECTION ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE >D> AP TEVA EQ 2MG BASE/ML A 076759 001 Nov 22, 2006 Aug DISC >A> @ EQ 2MG BASE/ML A 076759 001 Nov 22, 2006 Aug DISC

OXYBUTYNIN CHLORIDE TABLET, EXTENDED RELEASE;ORAL OXYBUTYNIN CHLORIDE >D> AB ACCORD HLTHCARE 15MG A 207138 003 Feb 29, 2016 Aug CHRS >A> AB ! 15MG A 207138 003 Feb 29, 2016 Aug CHRS >D> AB ! MYLAN PHARMS INC 15MG A 076644 002 May 10, 2007 Aug CHRS >A> AB 15MG A 076644 002 May 10, 2007 Aug CHRS

Page 19 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PALIPERIDONE TABLET, EXTENDED RELEASE;ORAL PALIPERIDONE >A> AB INVENTIA 1.5MG A 204452 001 Jun 12, 2019 Aug CAHN >A> AB 3MG A 204452 002 Jun 12, 2019 Aug CAHN >A> AB 6MG A 204452 003 Jun 12, 2019 Aug CAHN >A> AB 9MG A 204452 004 Jun 12, 2019 Aug CAHN >D> AB INVENTIA HLTHCARE 1.5MG A 204452 001 Jun 12, 2019 Aug CAHN >D> AB 3MG A 204452 002 Jun 12, 2019 Aug CAHN >D> AB 6MG A 204452 003 Jun 12, 2019 Aug CAHN >D> AB 9MG A 204452 004 Jun 12, 2019 Aug CAHN

PANTOPRAZOLE SODIUM INJECTABLE;IV (INFUSION) PANTOPRAZOLE SODIUM >A> AP SUN PHARM EQ 40MG BASE/VIAL A 077674 001 Aug 19, 2019 Aug NEWA TABLET, DELAYED RELEASE;ORAL PANTOPRAZOLE SODIUM >D> AB APOTEX INC EQ 20MG BASE A 090807 001 May 02, 2012 Aug CAHN >D> AB EQ 40MG BASE A 090807 002 May 02, 2012 Aug CAHN >A> AB RUBICON EQ 20MG BASE A 090807 001 May 02, 2012 Aug CAHN >A> AB EQ 40MG BASE A 090807 002 May 02, 2012 Aug CAHN

>A> PEXIDARTINIB HYDROCHLORIDE >A> CAPSULE;ORAL >A> TURALIO >A> +! DAIICHI SANKYO INC EQ 200MG BASE N 211810 001 Aug 02, 2019 Aug NEWA

PHENYLEPHRINE HYDROCHLORIDE SOLUTION;INTRAVENOUS PHENYLEPHRINE HYDROCHLORIDE >D> AP AMNEAL PHARMS CO 10MG/ML (10MG/ML) A 211079 001 Jul 05, 2018 Aug CTEC >A> AP1 10MG/ML (10MG/ML) A 211079 001 Jul 05, 2018 Aug CTEC >D> AP 50MG/5ML (10MG/ML) A 211078 001 Jul 19, 2018 Aug CTEC >A> AP1 50MG/5ML (10MG/ML) A 211078 001 Jul 19, 2018 Aug CTEC >D> AP 100MG/10ML (10MG/ML) A 211078 002 Jul 19, 2018 Aug CTEC >A> AP1 100MG/10ML (10MG/ML) A 211078 002 Jul 19, 2018 Aug CTEC >D> AP FRESENIUS KABI USA 50MG/5ML (10MG/ML) A 210666 001 Jan 30, 2019 Aug CTEC >A> AP1 50MG/5ML (10MG/ML) A 210666 001 Jan 30, 2019 Aug CTEC >D> AP 100MG/10ML (10MG/ML) A 210666 002 Jan 30, 2019 Aug CTEC >A> AP1 100MG/10ML (10MG/ML) A 210666 002 Jan 30, 2019 Aug CTEC >D> AP MEITHEAL 10MG/ML (10MG/ML) A 210334 001 Apr 27, 2018 Aug CTEC >A> AP2 10MG/ML (10MG/ML) A 210334 001 Apr 27, 2018 Aug CTEC >D> AP 50MG/5ML (10MG/ML) A 210333 001 Apr 27, 2018 Aug CTEC >A> AP1 50MG/5ML (10MG/ML) A 210333 001 Apr 27, 2018 Aug CTEC >D> AP 100MG/10ML (10MG/ML) A 210333 002 Apr 27, 2018 Aug CTEC >A> AP1 100MG/10ML (10MG/ML) A 210333 002 Apr 27, 2018 Aug CTEC >D> AP PAR STERILE PRODUCTS 10MG/ML (10MG/ML) A 210025 001 Dec 21, 2018 Aug CTEC >A> AP1 10MG/ML (10MG/ML) A 210025 001 Dec 21, 2018 Aug CTEC >D> AP 50MG/5ML (10MG/ML) A 210025 002 Dec 21, 2018 Aug CTEC >A> AP1 50MG/5ML (10MG/ML) A 210025 002 Dec 21, 2018 Aug CTEC >D> AP 100MG/10ML (10MG/ML) A 210025 003 Dec 21, 2018 Aug CTEC >A> AP1 100MG/10ML (10MG/ML) A 210025 003 Dec 21, 2018 Aug CTEC >D> AP SANDOZ INC 10MG/ML (10MG/ML) A 208905 001 Jan 31, 2019 Aug CTEC >A> AP1 10MG/ML (10MG/ML) A 208905 001 Jan 31, 2019 Aug CTEC >D> AP 50MG/5ML (10MG/ML) A 208905 002 Jan 31, 2019 Aug CTEC >A> AP1 50MG/5ML (10MG/ML) A 208905 002 Jan 31, 2019 Aug CTEC >D> AP 100MG/10ML (10MG/ML) A 208905 003 Jan 31, 2019 Aug CTEC >A> AP1 100MG/10ML (10MG/ML) A 208905 003 Jan 31, 2019 Aug CTEC >D> AP +! WEST WARD PHARM CORP 10MG/ML (10MG/ML) N 203826 001 Dec 20, 2012 Aug CTEC >A> AP2 +! 10MG/ML (10MG/ML) N 203826 001 Dec 20, 2012 Aug CTEC >A> AP2 +! 50MG/5ML (10MG/ML) N 203826 002 Jun 19, 2019 Aug NEWA >A> AP2 +! 100MG/10ML (10MG/ML) N 203826 003 Jun 19, 2019 Aug NEWA VAZCULEP >D> AP + AVADEL LEGACY 10MG/ML (10MG/ML) N 204300 001 Jun 27, 2014 Aug CHRS >A> AP +! 10MG/ML (10MG/ML) N 204300 001 Jun 27, 2014 Aug CHRS >D> AP + 50MG/5ML (10MG/ML) N 204300 002 Jun 27, 2014 Aug CHRS >A> AP +! 50MG/5ML (10MG/ML) N 204300 002 Jun 27, 2014 Aug CHRS >D> AP +! 100MG/10ML (10MG/ML) N 204300 003 Jun 27, 2014 Aug CTEC

Page 20 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PHENYLEPHRINE HYDROCHLORIDE SOLUTION;INTRAVENOUS VAZCULEP >A> AP1 +! 100MG/10ML (10MG/ML) N 204300 003 Jun 27, 2014 Aug CTEC

PIMECROLIMUS CREAM;TOPICAL ELIDEL >A> AB +! BAUSCH 1% N 021302 001 Dec 13, 2001 Aug CAHN >D> AB +! VALEANT BERMUDA 1% N 021302 001 Dec 13, 2001 Aug CAHN PIMECROLIMUS >A> AB GLENMARK PHARMS LTD 1% A 211769 001 Aug 29, 2019 Aug NEWA

PIROXICAM CAPSULE;ORAL PIROXICAM >A> AB BRECKENRIDGE 10MG A 206136 001 Jun 20, 2017 Aug CAHN >A> AB 20MG A 206136 002 Jun 20, 2017 Aug CAHN >D> AB PII 10MG A 206136 001 Jun 20, 2017 Aug CAHN >D> AB 20MG A 206136 002 Jun 20, 2017 Aug CAHN

>A> PITOLISANT HYDROCHLORIDE >A> TABLET;ORAL >A> WAKIX >A> + BIOPROJET PHARMA EQ 4.45MG BASE N 211150 001 Aug 14, 2019 Aug NEWA >A> +! EQ 17.8MG BASE N 211150 002 Aug 14, 2019 Aug NEWA

POSACONAZOLE TABLET, DELAYED RELEASE;ORAL NOXAFIL >D> +! MERCK SHARP DOHME 100MG N 205053 001 Nov 25, 2013 Aug CFTG >A> AB +! 100MG N 205053 001 Nov 25, 2013 Aug CFTG >A> POSACONAZOLE >A> AB SINOTHERAPEUTICS INC 100MG A 212411 001 Aug 21, 2019 Aug NFTG

POTASSIUM CHLORIDE CAPSULE, EXTENDED RELEASE;ORAL POTASSIUM CHLORIDE >A> AB ANDA REPOSITORY 8MEQ A 205549 001 Dec 08, 2015 Aug CAHN >A> AB 10MEQ A 205549 002 Dec 08, 2015 Aug CAHN >D> AB PII 8MEQ A 205549 001 Dec 08, 2015 Aug CAHN >D> AB 10MEQ A 205549 002 Dec 08, 2015 Aug CAHN TABLET, EXTENDED RELEASE;ORAL POTASSIUM CHLORIDE >A> @ ANDA REPOSITORY 8MEQ A 206881 001 Jan 22, 2019 Aug CAHN >A> @ 10MEQ A 206881 002 Jan 22, 2019 Aug CAHN >A> AB1 BRECKENRIDGE 10MEQ A 206630 001 Mar 29, 2019 Aug CAHN >A> AB3 10MEQ A 210097 001 Jun 17, 2019 Aug CAHN >A> AB1 15MEQ A 206630 002 Mar 29, 2019 Aug CAHN >A> AB1 20MEQ A 206630 003 Mar 29, 2019 Aug CAHN >A> AB2 20MEQ A 210098 001 Apr 26, 2019 Aug CAHN >D> @ PII 8MEQ A 206881 001 Jan 22, 2019 Aug CAHN >D> AB1 10MEQ A 206630 001 Mar 29, 2019 Aug CAHN >D> @ 10MEQ A 206881 002 Jan 22, 2019 Aug CAHN >D> AB3 10MEQ A 210097 001 Jun 17, 2019 Aug CAHN >D> AB1 15MEQ A 206630 002 Mar 29, 2019 Aug CAHN >D> AB1 20MEQ A 206630 003 Mar 29, 2019 Aug CAHN >D> AB2 20MEQ A 210098 001 Apr 26, 2019 Aug CAHN

>A> PRETOMANID >A> TABLET;ORAL >A> PRETOMANID >A> +! TB ALLIANCE 200MG N 212862 001 Aug 14, 2019 Aug NEWA

RANOLAZINE TABLET, EXTENDED RELEASE;ORAL RANOLAZINE >A> AB CADILA 500MG A 210188 001 Aug 19, 2019 Aug NEWA >A> AB 1GM A 210188 002 Aug 19, 2019 Aug NEWA

Page 21 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

RISEDRONATE SODIUM TABLET;ORAL RISEDRONATE SODIUM >D> AB HANGZHOU BINJIANG 35MG A 207516 001 Feb 15, 2019 Aug DISC >A> @ 35MG A 207516 001 Feb 15, 2019 Aug DISC

RISPERIDONE TABLET;ORAL RISPERIDONE >A> AB CELLTRION 0.25MG A 078871 001 Oct 09, 2008 Aug CAHN >A> AB 0.5MG A 078871 002 Oct 09, 2008 Aug CAHN >A> AB 1MG A 078871 003 Oct 09, 2008 Aug CAHN >A> AB 2MG A 078871 004 Oct 09, 2008 Aug CAHN >A> AB 3MG A 078871 005 Oct 09, 2008 Aug CAHN >A> AB 4MG A 078871 006 Oct 09, 2008 Aug CAHN >D> AB HERITAGE PHARMA 0.25MG A 076228 001 Jun 30, 2008 Aug DISC >A> @ 0.25MG A 076228 001 Jun 30, 2008 Aug DISC >D> AB 0.5MG A 076228 002 Jun 30, 2008 Aug DISC >A> @ 0.5MG A 076228 002 Jun 30, 2008 Aug DISC >D> AB 1MG A 076228 003 Jun 30, 2008 Aug DISC >A> @ 1MG A 076228 003 Jun 30, 2008 Aug DISC >D> AB 2MG A 076228 004 Jun 30, 2008 Aug DISC >A> @ 2MG A 076228 004 Jun 30, 2008 Aug DISC >D> AB 3MG A 076228 005 Jun 30, 2008 Aug DISC >A> @ 3MG A 076228 005 Jun 30, 2008 Aug DISC >D> AB 4MG A 076228 006 Jun 30, 2008 Aug DISC >A> @ 4MG A 076228 006 Jun 30, 2008 Aug DISC >D> AB WOCKHARDT 0.25MG A 078871 001 Oct 09, 2008 Aug CAHN >D> AB 0.5MG A 078871 002 Oct 09, 2008 Aug CAHN >D> AB 1MG A 078871 003 Oct 09, 2008 Aug CAHN >D> AB 2MG A 078871 004 Oct 09, 2008 Aug CAHN >D> AB 3MG A 078871 005 Oct 09, 2008 Aug CAHN >D> AB 4MG A 078871 006 Oct 09, 2008 Aug CAHN

RIVASTIGMINE TARTRATE CAPSULE;ORAL EXELON >D> AB +! NOVARTIS EQ 1.5MG BASE N 020823 003 Apr 21, 2000 Aug DISC >A> + @ EQ 1.5MG BASE N 020823 003 Apr 21, 2000 Aug DISC >D> AB + EQ 3MG BASE N 020823 004 Apr 21, 2000 Aug DISC >A> + @ EQ 3MG BASE N 020823 004 Apr 21, 2000 Aug DISC >D> AB + EQ 4.5MG BASE N 020823 005 Apr 21, 2000 Aug DISC >A> + @ EQ 4.5MG BASE N 020823 005 Apr 21, 2000 Aug DISC >D> AB +! EQ 6MG BASE N 020823 006 Apr 21, 2000 Aug DISC >A> + @ EQ 6MG BASE N 020823 006 Apr 21, 2000 Aug DISC RIVASTIGMINE TARTRATE >D> AB DR REDDYS LABS INC EQ 1.5MG BASE A 077130 001 Oct 31, 2007 Aug CHRS >A> AB ! EQ 1.5MG BASE A 077130 001 Oct 31, 2007 Aug CHRS >D> AB EQ 6MG BASE A 077130 004 Oct 31, 2007 Aug CHRS >A> AB ! EQ 6MG BASE A 077130 004 Oct 31, 2007 Aug CHRS

ROCURONIUM BROMIDE INJECTABLE;INJECTION ROCURONIUM BROMIDE >D> AP CAMARGO PHARM 50MG/5ML (10MG/ML) A 210437 001 Aug 13, 2019 Aug CAHN >D> AP 100MG/10ML (10MG/ML) A 210437 002 Aug 13, 2019 Aug CAHN >A> AP SANOVEL ILAC 50MG/5ML (10MG/ML) A 210437 001 Aug 13, 2019 Aug CAHN >A> AP 100MG/10ML (10MG/ML) A 210437 002 Aug 13, 2019 Aug CAHN

ROPINIROLE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL ROPINIROLE HYDROCHLORIDE >A> AB CELLTRION EQ 2MG BASE A 091395 001 Aug 27, 2012 Aug CAHN >A> AB EQ 4MG BASE A 091395 002 Aug 27, 2012 Aug CAHN >A> AB EQ 6MG BASE A 091395 003 Aug 27, 2012 Aug CAHN >A> AB EQ 8MG BASE A 091395 004 Aug 27, 2012 Aug CAHN >A> AB EQ 12MG BASE A 091395 005 Aug 27, 2012 Aug CAHN >D> AB WOCKHARDT LTD EQ 2MG BASE A 091395 001 Aug 27, 2012 Aug CAHN >D> AB EQ 4MG BASE A 091395 002 Aug 27, 2012 Aug CAHN

Page 22 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ROPINIROLE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL ROPINIROLE HYDROCHLORIDE >D> AB EQ 6MG BASE A 091395 003 Aug 27, 2012 Aug CAHN >D> AB EQ 8MG BASE A 091395 004 Aug 27, 2012 Aug CAHN >D> AB EQ 12MG BASE A 091395 005 Aug 27, 2012 Aug CAHN

ROSUVASTATIN CALCIUM TABLET;ORAL ROSUVASTATIN CALCIUM >D> AB ZYDUS PHARMS 5MG A 206513 001 Mar 01, 2019 Aug DISC >A> @ 5MG A 206513 001 Mar 01, 2019 Aug DISC >D> AB 10MG A 206513 002 Mar 01, 2019 Aug DISC >A> @ 10MG A 206513 002 Mar 01, 2019 Aug DISC >D> AB 20MG A 206513 003 Mar 01, 2019 Aug DISC >A> @ 20MG A 206513 003 Mar 01, 2019 Aug DISC >D> AB 40MG A 206513 004 Mar 01, 2019 Aug DISC >A> @ 40MG A 206513 004 Mar 01, 2019 Aug DISC

SAPROPTERIN DIHYDROCHLORIDE POWDER;ORAL KUVAN >D> +! BIOMARIN PHARM 100MG/PACKET N 205065 001 Dec 19, 2013 Aug CFTG >A> AB +! 100MG/PACKET N 205065 001 Dec 19, 2013 Aug CFTG >D> + 500MG/PACKET N 205065 002 Oct 27, 2015 Aug CFTG >A> AB + 500MG/PACKET N 205065 002 Oct 27, 2015 Aug CFTG >A> SAPROPTERIN DIHYDROCHLORIDE >A> AB PAR PHARM INC 100MG/PACKET A 207207 001 Aug 20, 2019 Aug NFTG >A> AB 500MG/PACKET A 210027 001 Aug 20, 2019 Aug NFTG

SELEGILINE HYDROCHLORIDE TABLET;ORAL SELEGILINE HYDROCHLORIDE >D> AB MYLAN 5MG A 074866 001 Nov 26, 1997 Aug DISC >A> @ 5MG A 074866 001 Nov 26, 1997 Aug DISC

SODIUM CHLORIDE INJECTABLE;INJECTION SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER >D> +! LIEBEL-FLARSHEIM 405MG/50ML (9MG/ML) N 021569 001 Jul 27, 2006 Aug DISC >A> + @ 405MG/50ML (9MG/ML) N 021569 001 Jul 27, 2006 Aug DISC

SOFOSBUVIR >A> PELLETS;ORAL >A> SOVALDI >A> + GILEAD SCIENCES INC 150MG/PACKET N 212480 001 Aug 28, 2019 Aug NEWA >A> +! 200MG/PACKET N 212480 002 Aug 28, 2019 Aug NEWA TABLET;ORAL SOVALDI >A> + GILEAD SCIENCES INC 200MG N 204671 002 Aug 28, 2019 Aug NEWA

SOLIFENACIN SUCCINATE TABLET;ORAL SOLIFENACIN SUCCINATE >A> AB UNICHEM LABS LTD 5MG A 211701 001 Aug 27, 2019 Aug NEWA >A> AB 10MG A 211701 002 Aug 27, 2019 Aug NEWA

>A> SOMATROPIN >A> INJECTABLE;INJECTION >A> GENOTROPIN >A> BX +! PHARMACIA AND UPJOHN 5.8MG/VIAL N 020280 006 Aug 24, 1995 Aug CAIN >A> +! 13.8MG/VIAL N 020280 007 Oct 23, 1996 Aug CAIN >A> GENOTROPIN PRESERVATIVE FREE >A> + PHARMACIA AND UPJOHN 0.2MG/VIAL N 020280 001 Jan 27, 1998 Aug CAIN >A> + 0.4MG/VIAL N 020280 002 Jan 27, 1998 Aug CAIN >A> + 0.6MG/VIAL N 020280 003 Jan 27, 1998 Aug CAIN >A> + 0.8MG/VIAL N 020280 005 Jan 27, 1998 Aug CAIN >A> + 1MG/VIAL N 020280 008 Jan 27, 1998 Aug CAIN >A> + 1.2MG/VIAL N 020280 009 Jan 27, 1998 Aug CAIN >A> + 1.4MG/VIAL N 020280 010 Jan 27, 1998 Aug CAIN

Page 23 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

>A> SOMATROPIN >A> INJECTABLE;INJECTION >A> GENOTROPIN PRESERVATIVE FREE >A> + @ 1.5MG/VIAL N 020280 004 Aug 24, 1995 Aug CAIN >A> + 1.6MG/VIAL N 020280 011 Jan 27, 1998 Aug CAIN >A> + 1.8MG/VIAL N 020280 012 Jan 27, 1998 Aug CAIN >A> +! 2MG/VIAL N 020280 013 Jan 27, 1998 Aug CAIN >A> NORDITROPIN >A> @ NOVO NORDISK INC 5MG/1.5ML N 021148 001 Jun 20, 2000 Aug CAIN >A> @ 10MG/1.5ML N 021148 002 Jun 20, 2000 Aug CAIN >A> @ 15MG/1.5ML N 021148 003 Jun 20, 2000 Aug CAIN >A> NORDITROPIN FLEXPRO >A> BX NOVO NORDISK INC 5MG/1.5ML N 021148 008 Mar 01, 2010 Aug CAIN >A> BX 10MG/1.5ML N 021148 009 Mar 01, 2010 Aug CAIN >A> 15MG/1.5ML N 021148 010 Mar 01, 2010 Aug CAIN >A> 30MG/3ML N 021148 011 Jan 23, 2015 Aug CAIN >A> NORDITROPIN NORDIFLEX >A> @ NOVO NORDISK INC 5MG/1.5ML N 021148 004 Oct 01, 2004 Aug CAIN >A> @ 10MG/1.5ML N 021148 005 Oct 01, 2004 Aug CAIN >A> @ 15MG/1.5ML N 021148 006 Oct 01, 2004 Aug CAIN >A> @ 30MG/3ML N 021148 007 Mar 10, 2009 Aug CAIN >A> NUTROPIN >A> @ GENENTECH 5MG/VIAL N 020168 001 Nov 17, 1993 Aug CAIN >A> @ 10MG/VIAL N 020168 002 Nov 17, 1993 Aug CAIN >A> NUTROPIN AQ >A> @ GENENTECH 10MG/2ML (5MG/ML) N 020522 001 Dec 29, 1995 Aug CAIN >A> NUTROPIN AQ NUSPIN >A> +! GENENTECH 5MG/2ML (2.5MG/ML) N 020522 003 Jan 03, 2008 Aug CAIN >A> +! 10MG/2ML (5MG/ML) N 020522 005 Jan 03, 2008 Aug CAIN >A> +! 20MG/2ML (10MG/ML) N 020522 004 Jan 03, 2008 Aug CAIN >A> NUTROPIN AQ PEN >A> + @ GENENTECH 10MG/2ML (5MG/ML) N 020522 002 Apr 22, 2002 Aug CAIN >A> + @ 20MG/2ML (10MG/ML) N 020522 006 Jan 03, 2008 Aug CAIN >A> OMNITROPE >A> BX SANDOZ 1.5MG/VIAL N 021426 002 May 30, 2006 Aug CAIN >A> BX 5MG/1.5ML N 021426 003 Jan 16, 2008 Aug CAIN >A> BX 5.8MG/VIAL N 021426 001 May 30, 2006 Aug CAIN >A> BX 10MG/1.5ML N 021426 004 Aug 25, 2008 Aug CAIN >A> SAIZEN >A> @ EMD SERONO 4MG/VIAL N 019764 005 Jan 16, 2007 Aug CAIN >A> BX + 5MG/VIAL N 019764 002 Oct 08, 1996 Aug CAIN >A> @ 6MG/VIAL N 019764 001 Oct 08, 1996 Aug CAIN >A> +! 8.8MG/VIAL N 019764 003 Aug 29, 2000 Aug CAIN >A> SEROSTIM >A> EMD SERONO 4MG/VIAL N 020604 003 Jul 25, 1997 Aug CAIN >A> BX 5MG/VIAL N 020604 002 Aug 23, 1996 Aug CAIN >A> BX 6MG/VIAL N 020604 001 Aug 23, 1996 Aug CAIN >A> @ 8.8MG/VIAL N 020604 004 Sep 06, 2001 Aug CAIN >A> INJECTABLE;SUBCUTANEOUS >A> SEROSTIM LQ >A> @ EMD SERONO 6MG/0.5ML (6MG/0.5ML) N 020604 005 Feb 11, 2005 Aug CAIN

>D> SOMATROPIN RECOMBINANT >D> INJECTABLE;INJECTION >D> GENOTROPIN >D> BX +! PHARMACIA AND UPJOHN 5.8MG/VIAL N 020280 006 Aug 24, 1995 Aug CAIN >D> +! 13.8MG/VIAL N 020280 007 Oct 23, 1996 Aug CAIN >D> GENOTROPIN PRESERVATIVE FREE >D> + PHARMACIA AND UPJOHN 0.2MG/VIAL N 020280 001 Jan 27, 1998 Aug CAIN >D> + 0.4MG/VIAL N 020280 002 Jan 27, 1998 Aug CAIN >D> + 0.6MG/VIAL N 020280 003 Jan 27, 1998 Aug CAIN >D> + 0.8MG/VIAL N 020280 005 Jan 27, 1998 Aug CAIN >D> + 1MG/VIAL N 020280 008 Jan 27, 1998 Aug CAIN >D> + 1.2MG/VIAL N 020280 009 Jan 27, 1998 Aug CAIN >D> + 1.4MG/VIAL N 020280 010 Jan 27, 1998 Aug CAIN >D> + @ 1.5MG/VIAL N 020280 004 Aug 24, 1995 Aug CAIN >D> + 1.6MG/VIAL N 020280 011 Jan 27, 1998 Aug CAIN >D> + 1.8MG/VIAL N 020280 012 Jan 27, 1998 Aug CAIN >D> +! 2MG/VIAL N 020280 013 Jan 27, 1998 Aug CAIN

Page 24 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

>D> SOMATROPIN RECOMBINANT >D> INJECTABLE;INJECTION >D> NORDITROPIN >D> @ NOVO NORDISK INC 5MG/1.5ML N 021148 001 Jun 20, 2000 Aug CAIN >D> @ 10MG/1.5ML N 021148 002 Jun 20, 2000 Aug CAIN >D> @ 15MG/1.5ML N 021148 003 Jun 20, 2000 Aug CAIN >D> NORDITROPIN FLEXPRO >D> BX NOVO NORDISK INC 5MG/1.5ML N 021148 008 Mar 01, 2010 Aug CAIN >D> BX 10MG/1.5ML N 021148 009 Mar 01, 2010 Aug CAIN >D> 15MG/1.5ML N 021148 010 Mar 01, 2010 Aug CAIN >D> 30MG/3ML N 021148 011 Jan 23, 2015 Aug CAIN >D> NORDITROPIN NORDIFLEX >D> @ NOVO NORDISK INC 5MG/1.5ML N 021148 004 Oct 01, 2004 Aug CAIN >D> @ 10MG/1.5ML N 021148 005 Oct 01, 2004 Aug CAIN >D> @ 15MG/1.5ML N 021148 006 Oct 01, 2004 Aug CAIN >D> @ 30MG/3ML N 021148 007 Mar 10, 2009 Aug CAIN >D> NUTROPIN >D> @ GENENTECH 5MG/VIAL N 020168 001 Nov 17, 1993 Aug CAIN >D> @ 10MG/VIAL N 020168 002 Nov 17, 1993 Aug CAIN >D> NUTROPIN AQ >D> @ GENENTECH 10MG/2ML (5MG/ML) N 020522 001 Dec 29, 1995 Aug CAIN >D> NUTROPIN AQ NUSPIN >D> +! GENENTECH 5MG/2ML (2.5MG/ML) N 020522 003 Jan 03, 2008 Aug CAIN >D> +! 10MG/2ML (5MG/ML) N 020522 005 Jan 03, 2008 Aug CAIN >D> +! 20MG/2ML (10MG/ML) N 020522 004 Jan 03, 2008 Aug CAIN >D> NUTROPIN AQ PEN >D> + @ GENENTECH 10MG/2ML (5MG/ML) N 020522 002 Apr 22, 2002 Aug CAIN >D> + @ 20MG/2ML (10MG/ML) N 020522 006 Jan 03, 2008 Aug CAIN >D> OMNITROPE >D> BX SANDOZ 1.5MG/VIAL N 021426 002 May 30, 2006 Aug CAIN >D> BX 5MG/1.5ML N 021426 003 Jan 16, 2008 Aug CAIN >D> BX 5.8MG/VIAL N 021426 001 May 30, 2006 Aug CAIN >D> BX 10MG/1.5ML N 021426 004 Aug 25, 2008 Aug CAIN >D> SAIZEN >D> @ EMD SERONO 4MG/VIAL N 019764 005 Jan 16, 2007 Aug CAIN >D> BX + 5MG/VIAL N 019764 002 Oct 08, 1996 Aug CAIN >D> @ 6MG/VIAL N 019764 001 Oct 08, 1996 Aug CAIN >D> +! 8.8MG/VIAL N 019764 003 Aug 29, 2000 Aug CAIN >D> SEROSTIM >D> EMD SERONO 4MG/VIAL N 020604 003 Jul 25, 1997 Aug CAIN >D> BX 5MG/VIAL N 020604 002 Aug 23, 1996 Aug CAIN >D> BX 6MG/VIAL N 020604 001 Aug 23, 1996 Aug CAIN >D> @ 8.8MG/VIAL N 020604 004 Sep 06, 2001 Aug CAIN >D> INJECTABLE;SUBCUTANEOUS >D> SEROSTIM LQ >D> @ EMD SERONO 6MG/0.5ML (6MG/0.5ML) N 020604 005 Feb 11, 2005 Aug CAIN

SULFAMETHOXAZOLE; TRIMETHOPRIM INJECTABLE;INJECTION SULFAMETHOXAZOLE AND TRIMETHOPRIM >D> AP MYLAN LABS LTD 80MG/ML;16MG/ML A 206607 001 Aug 30, 2017 Aug CHRS >A> AP ! 80MG/ML;16MG/ML A 206607 001 Aug 30, 2017 Aug CHRS >D> AP ! TEVA PHARMS USA 80MG/ML;16MG/ML A 073303 001 Oct 31, 1991 Aug DISC >A> @ 80MG/ML;16MG/ML A 073303 001 Oct 31, 1991 Aug DISC

TAFLUPROST SOLUTION/DROPS;OPHTHALMIC >A> TAFLUPROST >A> AT MICRO LABS 0.0015% A 209051 001 Aug 19, 2019 Aug NFTG ZIOPTAN >D> +! OAK PHARMS INC 0.0015% N 202514 001 Feb 10, 2012 Aug CFTG >A> AT +! 0.0015% N 202514 001 Feb 10, 2012 Aug CFTG

TAMOXIFEN CITRATE SOLUTION;ORAL SOLTAMOX >A> FORTOVIA EQ 20MG BASE/10ML N 021807 001 Oct 29, 2005 Aug CAHN >D> MIDATECH PHARMA US EQ 20MG BASE/10ML N 021807 001 Oct 29, 2005 Aug CAHN

Page 25 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

TAZAROTENE CREAM;TOPICAL TAZAROTENE >D> AB FOUGERA PHARMS INC 0.1% A 211175 001 Jan 28, 2019 Aug DISC >A> @ 0.1% A 211175 001 Jan 28, 2019 Aug DISC

TECHNETIUM TC-99M DISOFENIN KIT INJECTABLE;INJECTION >D> HEPATOLITE >D> PHARMALUCENCE N/A N 018467 001 Mar 16, 1982 Aug DISC >A> @ N/A N 018467 001 Mar 16, 1982 Aug DISC

TEGASEROD MALEATE TABLET;ORAL ZELNORM >A> + @ ALFASIGMA EQ 2MG BASE N 021200 001 Jul 24, 2002 Aug CAHN >A> + @ EQ 6MG BASE N 021200 002 Jul 24, 2002 Aug CAHN >D> + @ US WORLDMEDS LLC EQ 2MG BASE N 021200 001 Jul 24, 2002 Aug CAHN >D> + @ EQ 6MG BASE N 021200 002 Jul 24, 2002 Aug CAHN

TELMISARTAN TABLET;ORAL TELMISARTAN >D> AB HISUN PHARM HANGZHOU 20MG A 207843 001 Feb 19, 2019 Aug DISC >A> @ 20MG A 207843 001 Feb 19, 2019 Aug DISC >D> AB 40MG A 207843 002 Feb 19, 2019 Aug DISC >A> @ 40MG A 207843 002 Feb 19, 2019 Aug DISC >D> AB 80MG A 207843 003 Feb 19, 2019 Aug DISC >A> @ 80MG A 207843 003 Feb 19, 2019 Aug DISC >A> AB INVENTIA 20MG A 205150 001 Oct 30, 2015 Aug CAHN >A> AB 40MG A 205150 002 Oct 30, 2015 Aug CAHN >A> AB 80MG A 205150 003 Oct 30, 2015 Aug CAHN >D> AB INVENTIA HLTHCARE 20MG A 205150 001 Oct 30, 2015 Aug CAHN >D> AB 40MG A 205150 002 Oct 30, 2015 Aug CAHN >D> AB 80MG A 205150 003 Oct 30, 2015 Aug CAHN

TEMSIROLIMUS SOLUTION;INTRAVENOUS TEMSIROLIMUS >A> AP GLAND PHARMA LTD 25MG/ML (25MG/ML) A 207383 001 Aug 16, 2019 Aug NEWA

TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL TOLTERODINE TARTRATE >A> AB INVENTIA HLTHCARE 2MG A 204562 001 Aug 19, 2019 Aug NEWA >A> AB 4MG A 204562 002 Aug 19, 2019 Aug NEWA

TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL TARKA >D> AB + ABBVIE 1MG;240MG N 020591 003 Oct 22, 1996 Aug DISC >A> + @ 1MG;240MG N 020591 003 Oct 22, 1996 Aug DISC TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE >D> AB GLENMARK GENERICS 1MG;240MG A 079135 004 Aug 30, 2010 Aug CTEC >A> 1MG;240MG A 079135 004 Aug 30, 2010 Aug CTEC

TRIAMTERENE CAPSULE;ORAL DYRENIUM >D> + CONCORDIA 50MG N 013174 001 Aug 10, 1964 Aug CFTG >A> AB + 50MG N 013174 001 Aug 10, 1964 Aug CFTG >D> +! 100MG N 013174 002 Dec 07, 1974 Aug CFTG >A> AB +! 100MG N 013174 002 Dec 07, 1974 Aug CFTG >A> TRIAMTERENE >A> AB AGNITIO 50MG A 211581 001 Aug 19, 2019 Aug NFTG >A> AB 100MG A 211581 002 Aug 19, 2019 Aug NFTG

Page 26 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

>A> UPADACITINIB >A> TABLET, EXTENDED RELEASE;ORAL >A> RINVOQ >A> +! ABBVIE INC EQ 15MG BASE N 211675 001 Aug 16, 2019 Aug NEWA

VALPROIC ACID SYRUP;ORAL >D> DEPAKENE >D> AA +! ABBVIE 250MG/5ML N 018082 001 Feb 28, 1978 Aug DISC >A> + @ 250MG/5ML N 018082 001 Feb 28, 1978 Aug DISC VALPROIC ACID >D> AA PHARM ASSOC 250MG/5ML A 075379 001 Dec 15, 2000 Aug CHRS >A> AA ! 250MG/5ML A 075379 001 Dec 15, 2000 Aug CHRS

VENLAFAXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL VENLAFAXINE HYDROCHLORIDE >A> AB CADILA PHARMS LTD EQ 75MG BASE A 211323 001 Aug 29, 2019 Aug NEWA >A> AB EQ 150MG BASE A 211323 002 Aug 29, 2019 Aug NEWA >A> AB EQ 225MG BASE A 211323 003 Aug 29, 2019 Aug NEWA

ZOLPIDEM TARTRATE TABLET;ORAL ZOLPIDEM TARTRATE >D> AB WOCKHARDT 5MG A 078426 001 May 15, 2007 Aug DISC >A> @ 5MG A 078426 001 May 15, 2007 Aug DISC >D> AB 10MG A 078426 002 May 15, 2007 Aug DISC >A> @ 10MG A 078426 002 May 15, 2007 Aug DISC

ZONISAMIDE CAPSULE;ORAL ZONISAMIDE >A> AB CELLTRION 25MG A 077636 003 Jul 27, 2006 Aug CAHN >A> AB 50MG A 077636 002 Jul 27, 2006 Aug CAHN >A> AB 100MG A 077636 001 Dec 22, 2005 Aug CAHN >D> AB WOCKHARDT 25MG A 077636 003 Jul 27, 2006 Aug CAHN >D> AB 50MG A 077636 002 Jul 27, 2006 Aug CAHN >D> AB 100MG A 077636 001 Dec 22, 2005 Aug CAHN

Page 27 of 30 ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

CLOTRIMAZOLE CREAM;VAGINAL CLOTRIMAZOLE >D> ! ACTAVIS MID ATLANTIC 1% A 074165 001 Jul 16, 1993 Aug CAHN >A> ! P AND L 1% A 074165 001 Jul 16, 1993 Aug CAHN

DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM TABLET;ORAL NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE >D> @ ACTAVIS ELIZABETH 25MG;220MG A 207597 001 Jan 25, 2019 Aug CAHN >A> APOTEX INC 25MG;220MG A 211830 001 Aug 22, 2019 Aug NEWA >A> @ P AND L 25MG;220MG A 207597 001 Jan 25, 2019 Aug CAHN

DOCOSANOL CREAM;TOPICAL DOCOSANOL >D> ACTAVIS LABS UT INC 10% A 208754 001 Nov 19, 2018 Aug CAHN >A> P AND L 10% A 208754 001 Nov 19, 2018 Aug CAHN

ESOMEPRAZOLE MAGNESIUM TABLET, DELAYED RELEASE;ORAL ESOMEPRAZOLE MAGNESIUM >D> @ ACTAVIS ELIZABETH EQ 20MG BASE A 209202 001 Mar 05, 2019 Aug CAHN >A> @ P AND L EQ 20MG BASE A 209202 001 Mar 05, 2019 Aug CAHN

FAMOTIDINE TABLET;ORAL FAMOTIDINE >D> IVAX SUB TEVA PHARMS 10MG A 075512 001 Jul 26, 2001 Aug CAHN >A> P AND L 10MG A 075512 001 Jul 26, 2001 Aug CAHN

FEXOFENADINE HYDROCHLORIDE SUSPENSION;ORAL CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY >D> ACTAVIS MID ATLANTIC 30MG/5ML A 203330 001 Nov 18, 2014 Aug CAHN >A> P AND L 30MG/5ML A 203330 001 Nov 18, 2014 Aug CAHN CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES >D> ! ACTAVIS MID ATLANTIC 30MG/5ML A 203330 002 Nov 18, 2014 Aug CAHN >A> ! P AND L 30MG/5ML A 203330 002 Nov 18, 2014 Aug CAHN

IBUPROFEN SUSPENSION/DROPS;ORAL INFANT'S ADVIL >A> +! PFIZER 50MG/1.25ML N 020812 002 Jan 12, 2000 Aug NEWA PEDIATRIC ADVIL >D> +! PFIZER 100MG/2.5ML N 020812 001 Jan 30, 1998 Aug DISC >A> + @ 100MG/2.5ML N 020812 001 Jan 30, 1998 Aug DISC SUSPENSION;ORAL IBUPROFEN >D> ACTAVIS MID ATLANTIC 100MG/5ML A 074916 001 Apr 30, 1999 Aug CAHN >A> P AND L 100MG/5ML A 074916 001 Apr 30, 1999 Aug CAHN

LORATADINE; PSEUDOEPHEDRINE SULFATE TABLET, EXTENDED RELEASE;ORAL LORATADINE AND PSEUDOEPHEDRINE SULFATE >D> ACTAVIS LABS FL INC 10MG;240MG A 075706 001 Feb 21, 2003 Aug CAHN >A> P AND L 10MG;240MG A 075706 001 Feb 21, 2003 Aug CAHN

MICONAZOLE NITRATE CREAM, SUPPOSITORY;TOPICAL, VAGINAL M-ZOLE 3 COMBINATION PACK >D> ACTAVIS MID ATLANTIC 2%,200MG A 074926 001 Apr 16, 1999 Aug CAHN >A> P AND L 2%,200MG A 074926 001 Apr 16, 1999 Aug CAHN

Page 28 of 30 ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

MICONAZOLE NITRATE CREAM;VAGINAL MICONAZOLE 7 >D> ACTAVIS MID ATLANTIC 2% A 074164 001 Mar 29, 1996 Aug CAHN >A> P AND L 2% A 074164 001 Mar 29, 1996 Aug CAHN SUPPOSITORY;VAGINAL MICONAZOLE NITRATE >D> ACTAVIS PHARMA 100MG A 073507 001 Nov 19, 1993 Aug CAHN >A> P AND L 100MG A 073507 001 Nov 19, 1993 Aug CAHN

MINOXIDIL AEROSOL, FOAM;TOPICAL MINOXIDIL (FOR MEN) >A> P AND L 5% A 208092 001 Feb 17, 2017 Aug CAHN >D> WATSON LABS INC 5% A 208092 001 Feb 17, 2017 Aug CAHN MINOXIDIL (FOR WOMEN) >A> P AND L 5% A 208092 002 Jul 27, 2017 Aug CAHN >D> WATSON LABS INC 5% A 208092 002 Jul 27, 2017 Aug CAHN SOLUTION;TOPICAL MINOXIDIL (FOR MEN) >D> ACTAVIS MID ATLANTIC 2% A 074588 001 Apr 05, 1996 Aug CAHN >A> P AND L 2% A 074588 001 Apr 05, 1996 Aug CAHN MINOXIDIL EXTRA STRENGTH (FOR MEN) >D> ACTAVIS MID ATLANTIC 5% A 075518 001 Nov 17, 2000 Aug CAHN >A> P AND L 5% A 075518 001 Nov 17, 2000 Aug CAHN

NAPROXEN SODIUM TABLET;ORAL NAPROXEN SODIUM >A> YICHANG HUMANWELL EQ 200MG BASE A 212033 001 Aug 30, 2019 Aug NEWA

NICOTINE POLACRILEX GUM, CHEWING;BUCCAL NICOTINE POLACRILEX >D> ACTAVIS LABS NY INC EQ 2MG BASE A 074507 001 Mar 15, 1999 Aug CAHN >D> EQ 2MG BASE A 076569 001 Jul 29, 2004 Aug CAHN >D> EQ 2MG BASE A 078699 001 Dec 29, 2008 Aug CAHN >D> EQ 2MG BASE A 079216 001 Jul 08, 2009 Aug CAHN >D> EQ 2MG BASE A 204794 001 May 10, 2016 Aug CAHN >D> EQ 4MG BASE A 074707 001 Mar 19, 1999 Aug CAHN >D> EQ 4MG BASE A 076568 002 Jul 29, 2004 Aug CAHN >D> EQ 4MG BASE A 078697 001 Dec 29, 2008 Aug CAHN >D> EQ 4MG BASE A 079038 001 Jul 08, 2009 Aug CAHN >D> EQ 4MG BASE A 079219 001 Jul 08, 2009 Aug CAHN >D> EQ 4MG BASE A 204833 001 Feb 26, 2016 Aug CAHN >A> P AND L EQ 2MG BASE A 074507 001 Mar 15, 1999 Aug CAHN >A> EQ 2MG BASE A 076569 001 Jul 29, 2004 Aug CAHN >A> EQ 2MG BASE A 078699 001 Dec 29, 2008 Aug CAHN >A> EQ 2MG BASE A 079044 001 Jul 08, 2009 Aug CAHN >A> EQ 2MG BASE A 079216 001 Jul 08, 2009 Aug CAHN >A> EQ 2MG BASE A 204794 001 May 10, 2016 Aug CAHN >A> EQ 4MG BASE A 074707 001 Mar 19, 1999 Aug CAHN >A> EQ 4MG BASE A 076568 002 Jul 29, 2004 Aug CAHN >A> EQ 4MG BASE A 078697 001 Dec 29, 2008 Aug CAHN >A> EQ 4MG BASE A 079038 001 Jul 08, 2009 Aug CAHN >A> EQ 4MG BASE A 079219 001 Jul 08, 2009 Aug CAHN >A> EQ 4MG BASE A 204833 001 Feb 26, 2016 Aug CAHN >D> WATSON LABS EQ 2MG BASE A 079044 001 Jul 08, 2009 Aug CAHN TROCHE/LOZENGE;ORAL NICOTINE POLACRILEX >A> @ P AND L EQ 2MG BASE A 209206 001 Jun 26, 2018 Aug CAHN >A> @ EQ 2MG BASE A 209519 001 Jul 02, 2018 Aug CAHN >A> EQ 2MG BASE A 210712 001 Sep 06, 2019 Aug NEWA >A> @ EQ 4MG BASE A 209206 002 Jun 26, 2018 Aug CAHN

Page 29 of 30 ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

NICOTINE POLACRILEX TROCHE/LOZENGE;ORAL NICOTINE POLACRILEX >A> @ EQ 4MG BASE A 209519 002 Jul 02, 2018 Aug CAHN >A> EQ 4MG BASE A 210712 002 Sep 06, 2019 Aug NEWA >D> @ WATSON LABS INC EQ 2MG BASE A 209206 001 Jun 26, 2018 Aug CAHN >D> @ EQ 4MG BASE A 209206 002 Jun 26, 2018 Aug CAHN >D> @ WATSON LABS TEVA EQ 2MG BASE A 209519 001 Jul 02, 2018 Aug CAHN >D> @ EQ 4MG BASE A 209519 002 Jul 02, 2018 Aug CAHN

OMEPRAZOLE TABLET, DELAYED RELEASE;ORAL OMEPRAZOLE >D> APOTEX INC 20MG A 210070 001 Feb 11, 2019 Aug DISC >A> @ 20MG A 210070 001 Feb 11, 2019 Aug DISC

RANITIDINE HYDROCHLORIDE TABLET;ORAL RANITIDINE HYDROCHLORIDE >A> UNIQUE PHARM LABS EQ 75MG BASE A 210250 001 Aug 30, 2019 Aug NEWA >A> EQ 150MG BASE A 210228 001 Aug 30, 2019 Aug NEWA

CURRENT MONTH ADDS/DELETES LIST NOTE:

The List is sorted by Ingredient(s) and, within each grouping, by the Dosage Form; Route and then by trade name.

The individual product record contains the Therapeutic Equivalence Code, Reference Listed Drug symbol, Reference Standard Drug symbol, applicant holder, strength(s), New Drug Application number, product number, and approval date. The last two columns describe the action. The Action Month is the CS month the action occurred. The OB Action is the type of change that has occurred.

New ingredient(s), new dosage form; route(s), new trade names, and new product additions are preceded by >A> during the action month. The change month is the current CS month; the change code for new approvals is NEWA.

Changes to currently listed products will list two records. The deleted product record will be proceeded by >D>. The product record change addition being made will be preceded by >A>.

The change code description:

NEWA New drug product approval usually in the supplement month. NFTG New first time generic approval. CAHN** Applicant holder firm name has changed. CAIN Change. There has been a change in the Ingredient(s) name. All products will be deleted under the old name and all products will be added under the changed ingredient(s) name. CDFR Change. Dosage Form; Route of Administration. CFTG Change. A first time generic for the innovator product. A TE Code is added. CMFD Change. The product is moved from the Discontinued Section due to a change in marketing status. CMS1 Change. Miscellaneous addition to list. CMS2 Change. Miscellaneous deletion from list. CPOT Change. Potency amount/unit. CRLD Change. Reference Listed Drug. CHRS Change. Reference Standard. CTEC Change. Therapeutic Equivalence Code. CTNA Change. Trade Name. DISC Discontinued. The Rx or OTC listed product is not being marketed and will be moved to the discontinued section in the next edition.

**Note: The Cumulative Supplement (CS) currently displays a condensed 20 character collapsed applicant holder firm name and the Electronic Orange Book(EOB)query may display up to a 240 character full applicant holder firm name. An applicant holder firm name change usually changes both the collapsed name and long name. On occasion, only the long name is changed resulting in the CS displaying only the collapsed name for the >D> and >A> action. The new firm long name will display in the EOB query.

Page 30 of 30